Key Takeaways Olin expects $100 million-$120 million of 2026 savings and at least $250 million by 2028. The Huntsman merger could add $400 million or more in cost synergies if completed. Olin faces weak chemical demand, a $2.85 billion net debt load and negative first-half cash flow. Olin Corporation (OLN - Free Report) has been benefiting from cost savings under its Beyond250 program, Winchester growth, improving Epoxy margins and ongoing efforts to strengthen earnings and deleverage. The planned merger with Huntsman Corporation (HUN - Free Report) is also expected to generate meaningful synergies.
However, weak global chemical demand, Asian import competition, the Freeport VCM outage, weaker EDC and export caustic soda pricing, elevated leverage, legacy Shintech payments, merger costs and negative operating cash flow could weigh on margins, free cash flow, debt reduction and near-term financial flexibility.
The company’s shares have lost 26% over a year compared with the industry’s 2.2% rise.
Image Source: Zacks Investment Research
Let’s find out why OLN stock is worth retaining at the moment.
OLN to Gain From Cost Savings and Merger SynergiesOlin’s Beyond250 program is becoming a larger structural earnings lever as the company reduces fixed costs, improves manufacturing productivity and standardizes operations. Management now expects $100 million to $120 million of savings in 2026 and at least $250 million of year-end run-rate savings by 2028, supported by site optimization, contractor reductions and roughly 600 employee and contractor position eliminations by 2026 year-end.
The planned all-stock merger with Huntsman is expected to add another $400 million or more of cost synergies and integration benefits if completed. The transaction is targeted to close in the first half of 2027 and would expand Olin’s scale and chlorine optionality while management remains focused on deleveraging.
Olin’s Growth and Margin Recovery Support OutlookWinchester continues to benefit from the April 2025 acquisition of AMMO Inc.’s small-caliber ammunition assets, which broadened its exposure to military, law enforcement and specialty markets. In second-quarter 2026, sales rose 11.8% year over year to $500.3 million as commercial ammunition sales and military project revenue increased, while segment income rose to $28.1 million from $25 million.
Management also cited a commercial order backlog and consistent international military sales and project work. Commercial demand is expected to strengthen seasonally in third-quarter 2026, while price increases are intended to offset higher metals costs. These trends support Winchester’s long-term earnings contribution as acquired capacity and demand recovery develop.
Epoxy is showing a broader margin recovery even as global demand remains weak. Second-quarter 2026 sales increased 27.4% year over year to $422.1 million, while segment income improved to $16 million from a $23.7 million loss as pricing, volumes and lower operating costs offset higher raw material costs. For third-quarter 2026, management expects stable volume and better margins from mix, while lower U.S. hydrocarbon costs and ongoing U.S. and European price initiatives provide additional support.
Olin Faces Demand, Leverage and Cash Flow HeadwindsOlin’s chemicals businesses remain exposed to weak global demand and Asian import competition. In second-quarter 2026, Epoxy saw continued inflows of Asian imports into the United States and Europe, while management said seasonal demand was weaker than usual. Chlor Alkali Products and Vinyls’ first-half 2026 sales fell 17.2% year over year and segment income declined to $8.9 million from $143.2 million.
The Freeport VCM outage reduced second-quarter adjusted EBITDA by about $40 million and is expected to reduce third-quarter results by another $20 million. Management also expects weaker EDC and export caustic soda pricing to offset better domestic caustic pricing, leaving Chemicals results comparable to second-quarter 2026.
Olin ended second-quarter 2026 with net debt of $2.85 billion and net debt to adjusted EBITDA of 5 times versus 4.1 times at year-end 2025. It paid about $93 million toward legacy Shintech matters in the first half and expects roughly $100 million more in the second half. Acquisition-related merger costs are forecast at $35 million to $40 million for 2026. Management is targeting year-end leverage of about 4.5 times and plans to use excess cash flow for debt reduction.
Net operating cash flow was negative $40.7 million in the first half of 2026 versus positive $126.3 million a year earlier. Working capital increased $183 million during the period, although management expects seasonal working capital to be liquidated in the second half and be flat year over year, excluding Shintech payments.
Olin Corporation Price and ConsensusOLN’s Zacks Rank & Key PicksOLN currently carries a Zacks Rank #3 (Hold).
A couple of better-ranked stocks in the Basic Materials space are Materion Corporation (MTRN - Free Report) and L.B. Foster Company (FSTR - Free Report) . MTRN sports a Zacks Rank #1 (Strong Buy), while FSTR carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Materion’s current-year earnings is $6.81 per share, implying a 25.2% year-over-year increase. MTRN’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 6.6%.
The consensus estimate for L.B. Foster’s current-year earnings is pegged at $1.62 per share, implying a 134.8% year-over-year increase. FSTR’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the average surprise being 19.9%.
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation (“Olin” or the “Company”) (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by “an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas.” Olin said that “[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter.”
On this news, Olin’s stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by "an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas." Olin said that "[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter."
On this news, Olin's stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by "an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas." Olin said that "[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter."
On this news, Olin's stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation (“Olin” or the “Company”) (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by “an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas.” Olin said that “[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter.”
On this news, Olin’s stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
PTT Public (OTCMKTS:PCHUY – Get Free Report) and Olin (NYSE:OLN – Get Free Report) are both materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.
Earnings & Valuation This table compares PTT Public and Olin”s top-line revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PTT Public N/A N/A N/A $30.38 0.18 Olin $6.78 billion 0.32 -$100.50 million ($1.23) -15.47 PTT Public has higher earnings, but lower revenue than Olin. Olin is trading at a lower price-to-earnings ratio than PTT Public, indicating that it is currently the more affordable of the two stocks. Dividends PTT Public pays an annual dividend of $13.26 per share and has a dividend yield of 240.0%. Olin pays an annual dividend of $0.80 per share and has a dividend yield of 4.2%. PTT Public pays out 43.7% of its earnings in the form of a dividend. Olin pays out -65.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Institutional & Insider Ownership 88.7% of Olin shares are held by institutional investors. 1.6% of Olin shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Recommendations This is a breakdown of current ratings and price targets for PTT Public and Olin, as provided by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PTT Public 0 0 0 0 0.00 Olin 4 10 1 1 1.94 Olin has a consensus target price of $23.08, suggesting a potential upside of 21.27%. Given Olin’s stronger consensus rating and higher probable upside, analysts clearly believe Olin is more favorable than PTT Public.
Profitability This table compares PTT Public and Olin’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets PTT Public N/A N/A N/A Olin -2.08% -4.76% -1.17% Summary Olin beats PTT Public on 8 of the 14 factors compared between the two stocks.
About PTT Public (Get Free Report)
PTT Public Company Limited, together with its subsidiaries, engages in petroleum business in Thailand, rest of Asia, Europe, the Americas, and internationally. The company is involved in the exploration and production of petroleum; natural gas procurement, pipeline transmission, distribution, and separation activities; and management and maintenance services of port, LNG storage, and LNG station, as well as cooling management and other related businesses. In addition, it engages in the investment, mining, and marketing of coal; and marketing of petroleum products and lube oil through an operating system of procurement, storage, and distribution of products, as well as the retail business at service stations. Further, the company is involved in the import and export of petroleum and petrochemical products, as well as other related products; production and distribution of electricity, steam, and water for industrial purpose; and provision of project management, human resource support, petroleum related technology, consultant management, technical consultant for electricity businesses, petrol station and convenience store management, factory maintenance and engineering, oil and gas, and safety and environmental services, as well as engages in wind power project development. Additionally, it produces and distributes chilled water/constructs and installs electricity generating systems; develops electricity power production projects; distributes polymers products, and other polymers-related products; develops real estate; operates vocational schools; and manufactures and distributes biochemical products, paraxylene, and industrial coatings and additives, as well as engages in the transportation of polyethylene. It engages in the provision of financial and online car services; coffee and beverage business; and manufacturing and distributing petrochemical and health and nutrition products. The company was founded in 1978 and is headquartered in Bangkok, Thailand.
About Olin (Get Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents. The Epoxy segment provides Allylics, such as allyl chloride, epichlorohydrin, and glycerin; aromatics, including acetone, bisphenol, cumene, and phenol; liquid and solid epoxy resins; and converted epoxy resins and additives. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, gun clubs, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.
Receive News & Ratings for PTT Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PTT Public and related companies with MarketBeat.com's FREE daily email newsletter.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by "an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas." Olin said that "[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter."
On this news, Olin's stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation (“Olin” or the “Company”) (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Key Takeaways Olin posted in-line Q2 earnings, Revenues beat estimates and adjusted EBITDA rose 8.6%.Epoxy sales jumped 27.4% on higher volumes and pricing, while segment earnings improved to $16 million.Winchester sales rose 11.8% as commercial ammunition and military project revenues strengthened. Olin Corporation (OLN - Free Report) reported second-quarter net loss of $13.3 million, or 12 cents per share, compared with a loss of $1.3 million, or 1 cent, a year ago.
Barring one-time items, adjusted earnings were 7 cents per share, in line with the Zacks Consensus Estimate.
Revenues declined 0.9% year over year to $1,741.9 million but beat the consensus estimate of $1,719.6 million by 1.3%. Adjusted EBITDA rose 8.6% to $191.3 million, supported by improved chemical pricing and stronger Epoxy and Winchester performance.
Segmental ReviewChlor Alkali Products and Vinyls sales were $819.5 million in the second quarter, down 16.3% year over year from $979.5 million. The reported figure missed the consensus estimate of $885 million. The decline primarily resulted from lower trading volumes associated with Blue Water Alliance and reduced vinyl chloride monomer volumes. The Blue Water Alliance joint venture concluded operations at the end of 2025. Segment earnings declined to $53.4 million from $64.9 million, with operating issues at the Freeport, TX, vinyl chloride monomer plant hurting results by $40.1 million.
Epoxy sales increased 27.4% year over year to $422.1 million from $331.2 million, driven by higher volumes and improved pricing. The metric beat the consensus estimate of $376 million. Segment earnings improved to $16 million from a year-ago loss of $23.7 million, reflecting higher volumes, improved product margins and lower operating costs. Higher selling prices supported margins, partly offset by elevated benzene and propylene costs.
Winchester sales rose 11.8% year over year to $500.3 million from $447.6 million. It outpaced the consensus estimate of $494 million. Growth was mainly driven by higher commercial ammunition sales and increased military project revenues. Segment earnings increased to $28.1 million from $25 million as higher commercial ammunition pricing and volumes and military project revenues more than offset higher commodity metal and operating costs.
FinancialsOlin ended the second quarter with cash and cash equivalents of $177.4 million. Net debt was $2.85 billion. Net cash used in operating activities was $40.7 million during the first six months of 2026. Dividends paid totaled $45.6 million for the period. No common stock repurchases and retirements were recorded in the first half of 2026.
OutlookFor the third quarter of 2026, Olin expects adjusted EBITDA in the range of $160 million to $200 million. The company expects its Chemical businesses’ results to be comparable with second-quarter levels as lower operating rates at the Freeport vinyl chloride monomer facility and weaker ethylene dichloride pricing offset anticipated stronger caustic soda volumes.
The Freeport disruption is expected to reduce third-quarter adjusted EBITDA by roughly $20 million, with full operating rates planned to resume late in the quarter. In Winchester, seasonally improving commercial demand is expected to support sequential earnings growth. Beyond 2026, the company expects the proposed Huntsman merger to close in the first half of 2027, subject to the required approvals and closing conditions.
Olin’s Price PerformanceShares of Olin have lost 1% in the past year against 6.1% rise of the industry.
Image Source: Zacks Investment Research
OLN’s Zacks Rank & Key PicksOLN currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks are Neo Performance Materials Inc. (NOPMF - Free Report) , CECO Environmental Corp. (CECO - Free Report) and Applied Industrial Technologies, Inc. (AIT - Free Report)
Neo Performance is slated to report second-quarter 2026 results on Aug. 11. The Zacks Consensus Estimate for earnings is pegged at 50 cents per share. NOPMF sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
CECO is slated to report second-quarter 2026 results on Aug. 10. The consensus estimate for CECO’s earnings per share is pegged at 24 cents. CECO presently sports a Zacks Rank #1.
Applied Industrial is scheduled to report fourth-quarter fiscal 2026 results on Aug. 13. The Zacks Consensus Estimate for AIT’s fourth-quarter earnings per share is pegged at $2.92. AIT carries a Zacks Rank #2 (Buy) at present.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Olin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 30, 2026, Olin reported its financial results for the second quarter of 2026. Among other items, Olin disclosed that its financial performance was impacted by "an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas." Olin said that "[t]he disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter."
On this news, Olin's stock price fell $3.66 per share, or 16.51%, to close at $18.51 per share on July 31, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Olin (NYSE:OLN – Get Free Report) and Asahi Glass (OTCMKTS:ASGLY – Get Free Report) are both mid-cap materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.
Analyst Recommendations This is a breakdown of recent recommendations and price targets for Olin and Asahi Glass, as provided by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Olin 4 9 2 1 2.00 Asahi Glass 0 1 0 0 2.00 Olin presently has a consensus target price of $23.38, suggesting a potential upside of 25.69%. Given Olin’s higher possible upside, equities analysts clearly believe Olin is more favorable than Asahi Glass.
Earnings & Valuation This table compares Olin and Asahi Glass”s revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Olin $6.78 billion 0.31 -$100.50 million ($1.23) -15.13 Asahi Glass $13.77 billion 0.60 $463.39 million $0.53 14.38 Asahi Glass has higher revenue and earnings than Olin. Olin is trading at a lower price-to-earnings ratio than Asahi Glass, indicating that it is currently the more affordable of the two stocks.
Profitability This table compares Olin and Asahi Glass’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Olin -2.08% -4.76% -1.17% Asahi Glass 4.04% 5.02% 2.89% Volatility and Risk Olin has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Asahi Glass has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500.
Dividends Olin pays an annual dividend of $0.80 per share and has a dividend yield of 4.3%. Asahi Glass pays an annual dividend of $0.16 per share and has a dividend yield of 2.1%. Olin pays out -65.0% of its earnings in the form of a dividend. Asahi Glass pays out 30.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Olin is clearly the better dividend stock, given its higher yield and lower payout ratio.
Insider & Institutional Ownership 88.7% of Olin shares are owned by institutional investors. 1.6% of Olin shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
About Olin (Get Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents. The Epoxy segment provides Allylics, such as allyl chloride, epichlorohydrin, and glycerin; aromatics, including acetone, bisphenol, cumene, and phenol; liquid and solid epoxy resins; and converted epoxy resins and additives. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, gun clubs, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.
About Asahi Glass (Get Free Report)
AGC Inc. manufactures and sells glass, automotive, electronics, chemicals, and ceramics worldwide. The company offers architectural glass products, including laminated, insulating, wired, solar control, toughened, decorative, sound insulation, float and patterned, and industrial glasses; structural glazing systems; and automotive glass, such as laminated, tempered, and privacy glasses, as well as integrated glass antennas and module assembly windows. It also provides glass substrates for thin-film-transistor liquid crystal displays and OLEDs; synthetic fused silica glass, synthetic quartz crystals, silicon carbides, CMP slurry, through glass Vias, high refractive index glass, diffusers, glass ceramics substrates, optical planar devices, IR cut filters, aspherical glass and molded lens, and micro lens array products; polycarbonate and optical sheets, thin sheets, and films; and glass frits and pastes, as well as glass substrates for semiconductor packaging and other electronic materials. In addition, the company offers cover glass for smartphones and tablet devices; glass substrates for photovoltaic devices and touch panels; specialty glass; extra clear float glass; transparent conductive oxide glass for a-Si type solar module; and ultra-thin glass for electronics devices. Further, it provides chlor-alkali, polyurethanes, fluoro, and specialty chemical products; high thermal insulation ceramics wall for furnaces; and ceramic beads, sputtering targets, abrasion resistant ceramics, alumina cement, engineering fine ceramics, and ceramics molding agents for 3D printers. Additionally, the company engages in the digital signage on glass, copper clad laminate, and plastic optical fiber businesses; and gas and solvents, and life Science businesses. The company was formerly known as Asahi Glass Co., Ltd. and changed its name to AGC Inc. in July 2018. AGC Inc. was founded in 1907 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
3 Stocks Ringing in The New Year With Large Buyback AnnouncementsOlin NYSE: OLN said its second-quarter performance was shaped by supply-chain disruptions tied to the conflict involving Iran, improved epoxy pricing, a recovery in commercial ammunition demand and an unplanned outage at its Freeport, Texas, vinyl chloride monomer facility.
Get Olin alerts:
President and CEO Ken Lane said the company’s Chlor-Alkali and Vinyls business benefited early in the quarter as disruptions lifted chemical prices and raised feedstock and energy costs globally. Export prices for caustic soda and ethylene dichloride, or EDC, later declined as supply chains rebalanced, though they remained above pre-conflict levels.
The Top 3 Materials Stocks to Buy in November“Caustic soda and EDC export pricing was a second quarter bright spot,” Lane said, adding that the favorable pricing was partially offset by the Freeport VCM outage.
Freeport Outage and Chemicals Outlook The Freeport VCM plant experienced an isolated equipment issue in early May and restarted by mid-month, Lane said. However, the facility will operate at reduced rates through the third quarter while Olin completes repairs.
The outage reduced second-quarter adjusted EBITDA by $40 million, with an additional estimated $20 million impact expected in the third quarter. Lane said Olin expects to recover that impact in the fourth quarter once the asset returns to full capacity, assuming repairs continue as planned.
For the third quarter, Olin expects stronger domestic caustic soda pricing and higher export volumes for caustic soda and EDC. Those benefits are expected to be largely offset by lower export prices. The company also expects planned industry shutdowns and persistently higher feedstock and energy costs to tighten product availability in the fourth quarter.
Lane said demand in end markets including housing and automotive remains stable, though it has not yet recovered. He also cited lower operating rates in China and expected North American outages as potentially constructive for market balances later in the year.
Merchant chlorine sales improved seasonally in the second quarter, helped by demand from water treatment, refrigerant and other derivative markets. Several planned customer shutdowns are expected to reduce chlorine volumes in the third quarter, while chlorine pricing is expected to remain stable.
Epoxy Returns to Positive Earnings Olin’s epoxy business posted what Lane described as its best results in more than three years. The company raised prices during the quarter to address rising raw-material and transportation costs as hydrocarbon feedstocks became more expensive and less available.
U.S. epoxy resin demand experienced moderate seasonal improvement, particularly in construction-related applications such as coatings, while European demand remained flat. Lane said Europe did not see its normal seasonal improvement and faces continued pressure from higher energy costs and weak housing and industrial activity.
Olin said its new supply agreements in Stade, Germany, and the closure of its Guarujá, Brazil, facility have reduced annual epoxy structural costs by more than $50 million. Combined with the company’s commercial strategy, those actions returned the business to positive earnings.
Chief Financial Officer Todd Slater said epoxy is expected to generate positive EBITDA again in the third quarter, though results should be slightly lower than the second quarter because of higher European first-in, first-out raw-material costs. Olin has announced price increases intended to address elevated hydrocarbon and raw-material expenses.
Winchester Demand and Cost Actions Winchester’s commercial ammunition business continued to improve year over year as consumer demand strengthened, Lane said. The company has been raising prices to offset higher costs for copper and brass, while domestic and international military ammunition and project sales remained strong.
Olin expects Winchester’s third-quarter earnings to improve sequentially, supported by the fall hunting season, higher commercial volumes and pricing. Rising metals costs are expected to partially offset those gains.
Lane said imported ammunition has become less competitive because of tariffs that are now generally 20% and, in some cases, higher. He said this should remain a tailwind for Winchester’s commercial business.
The company also said it has already realized a significant portion of its previously identified $30 million of Winchester cost reductions through efficiency actions and workforce-sizing efforts. Olin recently began additional Beyond 250 work at Winchester’s Lake City, Missouri, facility and said it could exceed its $30 million cost-reduction target for the business.
Huntsman Merger, Cash Flow and Third-Quarter Guidance Olin is moving forward with its planned merger with Huntsman, announced June 16. Lane said the combination would create a vertically integrated, North America-focused chemical company with more than $12 billion in sales.
The company filed its definitive proxy on July 13, with a special shareholder meeting scheduled for Aug. 25. Olin expects to begin pre-closing integration planning in the third quarter and continues to target $400 million of synergies following an anticipated first-half 2027 closing.
Slater said Olin ended the quarter with $1.2 billion of available liquidity, including unused revolving-credit capacity, and has no bond maturities before 2029. Working capital increased $183 million in the first half, reflecting normal seasonal needs and $93 million in payments tied to legacy Shintech litigation matters.
Olin expects to pay the remaining $100 million related to those litigation matters during the second half of 2026. The company expects year-end leverage of about 4.5 times and said excess cash flow would be directed toward debt reduction. It continues to target approximately $200 million in 2026 capital spending and expects 2026 to be a cash-free-tax year, plus or minus $20 million.
For the third quarter, Olin expects Chemicals adjusted EBITDA to be relatively flat, modest improvement at Winchester and a sequential headwind from corporate costs. Overall adjusted EBITDA is expected to be between $160 million and $200 million.
Slater said Olin remains on track to deliver more than $100 million of incremental structural savings in 2026 under its Beyond 250 initiative and is increasingly confident it will exceed its $250 million savings target by 2028.
About Olin (NYSE:OLN)Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company's core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin's chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Olin Right Now?Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Shares of chemicals-and-ammunition-maker Olin Corp (OLN -18.29%), soon to merge with Huntsman (HUN -19.14%), tumbled 17.8% through 11:35 a.m. ET Friday after missing earnings last night.
Heading into the report, analysts forecast Olin would earn $0.12 per share on sales of $1.8 billion. Sales came up short at $1.7 billion, though, and instead of reporting a 12-cent profit, Olin reported a loss of $0.12 per share.
Oops.
Image source: Getty Images.
Olin Q2 earnings Olin operates three main businesses: Chlor Alkali Products and Vinyls, where sales declined 14% year over year; Epoxy, where sales grew 27%; and Winchester -- the ammunition company -- which posted 12% sales growth.
The two gainers balanced out the single declining business, and when all was said and done, Olin ended up with sales shrinking only 1% year over year.
(That's the good news. The bad news is that the tiny sales decline didn't prevent Olin's losses from soaring 12x in size, from $0.01 per share a year ago, to $0.12 this time around.)
Today's Change
(
-18.29
%) $
-4.06
Current Price
$
18.12
What's next for Olin stock But here's what investors need to consider: Olin is in the process of conducting a merger of equals with chemicals company Huntsman. It probably had an incentive, therefore, to take a "big bath" approach to its bad news this past quarter, cramming as many losses as possible into the quarter so that future quarters, post-merger, will look better by comparison -- and so management will look smarter for undertaking the merger.
Saying that "second quarter 2026 results included acquisition-related costs of $10.6 million related to this pending merger" further suggests that this is what was going on.
Will it work out for Olin? That remains to be seen -- as does whether the merger even happens. Closing is only scheduled to happen sometime in early 2027, so... stay tuned.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
For the quarter ended June 2026, Olin (OLN - Free Report) reported revenue of $1.74 billion, down 0.9% over the same period last year. EPS came in at $0.07, compared to $0.05 in the year-ago quarter.
The reported revenue represents a surprise of +1.3% over the Zacks Consensus Estimate of $1.72 billion. With the consensus EPS estimate being $0.07, the company has not delivered EPS surprise.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Olin performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Sales- Epoxy: $422.1 million compared to the $376.11 million average estimate based on three analysts. The reported number represents a change of +27.5% year over year.Sales- Chlor Alkali Products and Vinyls: $819.5 million versus the three-analyst average estimate of $884.61 million. The reported number represents a year-over-year change of -16.3%.Sales- Winchester: $500.3 million versus $493.57 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.8% change.Income (Loss) before Taxes- Winchester: $28.1 million compared to the $16.96 million average estimate based on two analysts.Income (Loss) before Taxes- Epoxy: $16 million versus the two-analyst average estimate of $7.35 million.View all Key Company Metrics for Olin here>>>
Shares of Olin have returned +13.3% over the past month versus the Zacks S&P 500 composite's -1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Olin (OLN - Free Report) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this chlor-alkali and ammunition producer' would post a loss of $0.67 per share when it actually produced a loss of $0.65, delivering a surprise of +2.99%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Olin, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $1.74 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.30%. This compares to year-ago revenues of $1.76 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Olin shares have added about 6.5% since the beginning of the year versus the S&P 500's gain of 6.9%.
What's Next for Olin?While Olin has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Olin was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.22 on $1.71 billion in revenues for the coming quarter and -$0.41 on $6.66 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Chemours (CC - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 4.
This chemical company is expected to post quarterly earnings of $0.43 per share in its upcoming report, which represents a year-over-year change of -25.9%. The consensus EPS estimate for the quarter has been revised 4.4% lower over the last 30 days to the current level.
Chemours' revenues are expected to be $1.67 billion, up 3.7% from the year-ago quarter.
Second quarter 2026 net loss of ($13.3) million, or ($0.12) per diluted share Quarterly adjusted EBITDA of $191.3 million , /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the second quarter ended June 30, 2026. Second quarter 2026 reported net loss was ($13.3) million, or ($0.12) per diluted share, which compares to second quarter 2025 reported net loss of ($1.3) million, or ($0.01) per diluted share. Second quarter 2026 adjusted EBITDA of $191.3 million excludes depreciation and amortization expense of $122.1 million, acquisition-related costs of $10.6 million, and restructuring charges of $10.5 million. Second quarter 2025 adjusted EBITDA was $176.1 million. Sales in the second quarter 2026 were $1,741.9 million, compared to $1,758.3 million in the second quarter 2025.
Ken Lane, President and Chief Executive Officer, said, "The Olin team delivered sequential improvement in adjusted EBITDA in a highly volatile environment. Our Chlor Alkali Products and Vinyls business benefited from improved caustic soda and ethylene dichloride pricing and from favorable operating performance driven by our Beyond250 structural cost actions. However, partially offsetting this performance was an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas. Operations have resumed at reduced rates. The disruption reduced second quarter adjusted EBITDA by $40 million, with an estimated $20 million impact expected in the third quarter as full rates are planned to resume late in the quarter. Epoxy continued to improve as margins expanded despite persistent weak demand conditions in Europe. Winchester's sequential improvement was driven by stronger commercial demand and pricing actions implemented to offset commodity metals and raw materials cost inflation.
"Looking ahead, we expect our Chemical businesses' third quarter 2026 results to be comparable to the second quarter, as reduced operating rates at the vinyl chloride monomer facility and weaker ethylene dichloride pricing offset expected stronger caustic soda volumes. In our Winchester business, seasonally improving commercial demand is expected to support sequential earnings growth. With continued significant global volatility, third quarter 2026 adjusted EBITDA is forecast to be in the range of $160 million to $200 million," Lane concluded.
SEGMENT REPORTING
Olin defines segment earnings as income (loss) before interest expense, net, other operating income (expense), non-operating pension income, other income, and income taxes.
CHLOR ALKALI PRODUCTS AND VINYLS
Chlor Alkali Products and Vinyls sales for the second quarter 2026 were $819.5 million, compared to $979.5 million in the second quarter 2025. The decrease in sales was due to lower volumes, primarily resulting from lower trading volumes associated with Blue Water Alliance and lower vinyl chloride monomer volumes. The Blue Water Alliance joint venture concluded operations at the end of 2025. Second quarter 2026 segment earnings were $53.4 million, compared to $64.9 million in the second quarter 2025. Second quarter 2026 segment results were negatively impacted by $40.1 million from operating issues with the vinyl chloride monomer plant at the Freeport, Texas facility resulting in higher costs and reduced profit from lost sales. The remaining $28.6 million increase in segment earnings was primarily due to higher pricing, primarily caustic soda and ethylene dichloride, partially offset by higher raw material costs, primarily natural gas and electrical power costs. Chlor Alkali Products and Vinyls second quarter 2026 results included depreciation and amortization expense of $98.1 million compared to $106.3 million in the second quarter 2025.
EPOXY
Epoxy sales for the second quarter 2026 were $422.1 million, compared to $331.2 million in the second quarter 2025. The increase in sales was due to higher volumes and improved pricing. Second quarter 2026 segment earnings were $16.0 million, compared to a segment loss of ($23.7) million in the second quarter 2025. The $39.7 million increase in segment results was primarily due to higher volumes, improved product margins, and lower operating costs. Product margins improved year-over-year with higher pricing partially offset by higher raw material costs, primarily benzene and propylene. Epoxy second quarter 2026 results included depreciation and amortization expense of $11.7 million compared to $13.1 million in the second quarter 2025.
WINCHESTER
Winchester sales for the second quarter 2026 were $500.3 million, compared to $447.6 million in the second quarter 2025. The increase in sales was primarily due to higher commercial ammunition sales and higher military project revenue. Second quarter 2026 segment earnings were $28.1 million, compared to $25.0 million in the second quarter 2025. The $3.1 million increase in segment earnings was primarily due to higher commercial ammunition pricing and volume and higher military project revenue, partially offset by higher raw material costs, primarily commodity metal costs, and higher operating costs. Winchester second quarter 2026 results included depreciation and amortization expense of $8.8 million compared to $7.9 million in the second quarter 2025.
CORPORATE AND OTHER COSTS
Other corporate and unallocated costs in the second quarter of 2026 increased $5.4 million compared to the second quarter 2025 primarily due to an unfavorable impact from foreign currency, partially offset by lower stock-based compensation, which includes mark-to-market adjustments.
PROPOSED MERGER OF EQUALS
On June 16, 2026, Olin and Huntsman Corporation announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to form a combined company, OlinHuntsman Corporation. Second quarter 2026 results included acquisition-related costs of $10.6 million related to this pending merger.
Completion of the merger, which is expected to occur in the first half of 2027, is subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals and approval of the merger by both Olin shareholders and Huntsman stockholders.
LIQUIDITY
The cash balance on June 30, 2026, was $177.4 million. Olin ended the second quarter 2026 with net debt of approximately $2.85 billion and a net debt to adjusted EBITDA ratio of 5.0 times. On June 30, 2026, Olin had available liquidity of approximately $1.2 billion, including unrestricted access to the undrawn portion of its revolving credit facility. Working capital increased $183.0 million in the first half 2026. In addition to the normal seasonal working capital built in first half of the year, which we expect to liquidate during the second half, Olin paid approximately $93 million, including previously accrued reserves, to resolve legacy Shintech litigation matters and expect to pay the remaining approximately $100 million in the second half of 2026.
CONFERENCE CALL INFORMATION
Olin senior management will host a conference call to discuss second quarter 2026 financial results at 9:00 a.m. Eastern Time on Friday, July 31, 2026. Remarks will be followed by a question-and-answer session. Associated slides and the conference call webcast are accessible via Olin's website, www.olin.com, under the second quarter conference call icon. An archived replay of the webcast will also be available in the Investor Relations section of Olin's website beginning at 12:00 p.m. Eastern Time. A final transcript of the call will be posted the next business day.
COMPANY DESCRIPTION
Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges, and clay targets, along with contracted U.S. military project revenue.
Visit www.olin.com for more information on Olin Corporation.
FORWARD-LOOKING STATEMENTS
This communication includes forward-looking statements. These statements relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future results, and current expectations, estimates and projections about the markets and economy in which we and our various segments operate. These statements may include statements regarding the proposed merger with Huntsman Corporation (Huntsman), the expected timetable for completing the merger, benefits and synergies of the merger, and future opportunities for the combined company following the transaction. The statements contained in this communication that are not statements of historical fact may include forward-looking statements that involve a number of risks and uncertainties.
We have used the words "anticipate," "intend," "may," "expect," "believe," "should," "plan," "outlook," "project," "estimate," "forecast," "optimistic," "target," and variations of such words and similar expressions in this communication to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions.
The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the SEC, including, without limitation, the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, and our Quarterly Reports on Form 10-Q and other reports furnished or filed with the SEC, include, but are not limited to, the following:
Business, Industry and Operational Risks
sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us; declines in average selling prices for our products and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products; unsuccessful execution of our operating model, which prioritizes Electrochemical Unit (ECU) margins over sales volumes; failure to control costs and inflation impacts or failure to achieve targeted cost reductions; availability of and/or higher-than-expected costs of raw material, energy, transportation, and/or logistics; our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation; the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards; exposure to physical risks associated with climate-related events or increased severity and frequency of severe weather events; the failure or an interruption, including cyber-attacks, of our information technology systems; risks associated with our international sales and operations, including economic, political or regulatory changes; weak industry conditions affecting our ability to comply with the financial maintenance covenants in our debt agreements; our indebtedness and debt service obligations; failure to identify, attract, develop, retain and motivate qualified employees throughout the organization and ability to manage executive officer and other key senior management transitions; adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital; our inability to complete future acquisitions or joint venture transactions or successfully integrate them into our business; the effects of any declines in global equity markets on asset values and any declines in interest rates or other significant assumptions used to value the liabilities in, and funding of, our pension plans; our long-range plan assumptions not being realized, causing a non-cash impairment charge of long-lived assets; Legal, Environmental and Regulatory Risks
changes in, or failure to comply with, legislation or government regulations or policies, including changes regarding our ability to manufacture or use certain products and changes within the international markets in which we operate; new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities; unexpected outcomes from legal or regulatory claims and proceedings; costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings; various risks associated with our Lake City U.S. Army Ammunition Plant contract and performance under other governmental contracts; Risks Relating to the Proposed Merger with Huntsman
factors relating to the satisfaction of the conditions to, and timely completion of, the proposed merger with Huntsman, including required shareholder and regulatory approvals; the possibility that the proposed merger may not be completed on the anticipated terms, timing, or at all, including the possibility of circumstances that would require us to pay a termination fee or reimburse certain expenses; the possibility that the expected strategic benefits, cost savings, operational efficiencies and synergies of the proposed merger may not be realized or may take longer to realize than expected; the effect of the proposed merger on relationships with employees, customers, suppliers and other business partners and adverse effects on our ability to attract, retain and motivate key personnel, maintain commercial relationships and execute our business strategy; the diversion of management attention from day-to-day operations and other strategic opportunities; transaction, advisory, legal, accounting, consulting, regulatory, retention, integration planning costs and other costs associated with the proposed merger; the Merger Agreement contains customary covenants that restrict our ability to undertake certain actions without Huntsman's consent prior to closing, which may limit operational flexibility and the ability to pursue certain business opportunities during the pendency of the transaction; and the risk of litigation, regulatory proceedings relating to the proposed merger, or the imposition of conditions, limitations, divestiture requirements or other remedies by governmental authorities. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements.
2026-10
Olin Corporation
Consolidated Statements of Operations(a)
Three Months Ended
June 30,
Six Months Ended
June 30,
($ in millions, except per share amounts)
2026
2025
2026
2025
Sales
$ 1,741.9
$ 1,758.3
$ 3,324.9
$ 3,402.5
Operating Expenses:
Cost of Goods Sold
1,571.7
1,620.2
3,078.9
3,115.7
Selling and Administrative
102.7
95.2
247.7
196.2
Restructuring Charges
10.5
7.4
19.6
11.4
Acquisition-related Costs(b)
10.6
—
10.6
—
Other Operating Income (Expense)
0.1
(0.2)
0.1
(0.2)
Operating Income (Loss)
46.5
35.3
(31.8)
79.0
Losses of Non-consolidated Affiliates
(1.0)
(1.4)
(2.4)
(1.4)
Interest Expense, Net
(44.3)
(45.6)
(86.4)
(92.9)
Non-operating Pension Income
2.6
4.9
6.1
10.6
Income (Loss) before Taxes
3.8
(6.8)
(114.5)
(4.7)
Income Tax Provision (Benefit)
17.1
(4.0)
(18.2)
(3.1)
Net Loss
(13.3)
(2.8)
(96.3)
(1.6)
Net Loss Attributable to Noncontrolling Interests
—
(1.5)
—
(1.7)
Net (Loss) Income Attributable to Olin Corporation
$ (13.3)
$ (1.3)
$ (96.3)
$ 0.1
Net (Loss) Income Attributable to Olin Corporation per Common Share:
Basic
$ (0.12)
$ (0.01)
$ (0.85)
$ —
Diluted
$ (0.12)
$ (0.01)
$ (0.85)
$ —
Dividends per Common Share
$ 0.20
$ 0.20
$ 0.40
$ 0.40
Average Common Shares Outstanding - Basic
113.9
114.9
113.8
115.1
Average Common Shares Outstanding - Diluted
113.9
114.9
113.8
115.9
(a) Unaudited.
(b) Acquisition-related costs for the three and six months ended June 30, 2026 included advisory, legal, accounting, and other professional fees associated with our proposed merger with Huntsman Corporation.
Olin Corporation
Segment Information(a)
Three Months Ended
June 30,
Six Months Ended
June 30,
($ in millions)
2026
2025
2026
2025
Sales:
Chlor Alkali Products and Vinyls
$ 819.5
$ 979.5
$ 1,576.4
$ 1,904.0
Epoxy
422.1
331.2
777.7
662.9
Winchester
500.3
447.6
970.8
835.6
Total Sales
$ 1,741.9
$ 1,758.3
$ 3,324.9
$ 3,402.5
Income (Loss) before Taxes:
Chlor Alkali Products and Vinyls
$ 53.4
$ 64.9
$ 8.9
$ 143.2
Epoxy
16.0
(23.7)
13.1
(52.1)
Winchester
28.1
25.0
43.3
47.8
Corporate/Other:
Environmental Expense
(5.7)
(4.8)
(10.9)
(9.8)
Other Corporate and Unallocated Costs
(25.3)
(19.9)
(58.5)
(39.9)
Restructuring Charges
(10.5)
(7.4)
(19.6)
(11.4)
Acquisition-related Costs(b)
(10.6)
—
(10.6)
—
Other Operating Income (Expense)
0.1
(0.2)
0.1
(0.2)
Interest Expense, Net
(44.3)
(45.6)
(86.4)
(92.9)
Non-operating Pension Income
2.6
4.9
6.1
10.6
Income (Loss) before Taxes
$ 3.8
$ (6.8)
$ (114.5)
$ (4.7)
(a) Unaudited.
(b) Acquisition-related costs for the three and six months ended June 30, 2026 included advisory, legal, accounting, and other professional fees associated with our proposed merger with Huntsman Corporation.
Olin Corporation
Consolidated Balance Sheets(a)
June 30,
December 31,
June 30,
($ in millions, except per share data)
2026
2025
2025
Assets:
Cash and Cash Equivalents
$ 177.4
$ 167.6
$ 223.8
Accounts Receivable, Net
988.6
844.5
1,044.5
Income Taxes Receivable
54.3
66.6
29.1
Inventories, Net
847.2
784.5
919.1
Other Current Assets
120.4
107.9
70.2
Total Current Assets
2,187.9
1,971.1
2,286.7
Property, Plant and Equipment (Less Accumulated Depreciation of
$5,587.3, $5,508.7 and $5,417.0)
2,089.0
2,196.9
2,260.8
Operating Lease Assets, Net
365.4
298.6
281.8
Deferred Income Taxes
45.2
47.2
59.7
Other Assets
1,169.8
1,210.0
1,159.7
Intangibles, Net
155.6
174.4
193.7
Goodwill
1,427.7
1,427.6
1,425.5
Total Assets
$ 7,440.6
$ 7,325.8
$ 7,667.9
Liabilities and Shareholders' Equity:
Current Installments of Long-term Debt
$ —
$ 109.7
$ 19.2
Accounts Payable
910.3
806.1
901.0
Income Taxes Payable
13.7
23.9
44.1
Current Operating Lease Liabilities
73.0
59.7
61.0
Accrued Liabilities
546.1
630.1
520.6
Total Current Liabilities
1,543.1
1,629.5
1,545.9
Long-term Debt
3,029.1
2,717.6
2,977.5
Operating Lease Liabilities
305.4
252.5
226.4
Accrued Pension Liability
197.2
200.9
227.4
Deferred Income Taxes
312.8
317.6
380.8
Other Liabilities
341.2
337.1
322.1
Total Liabilities
5,728.8
5,455.2
5,680.1
Commitments and Contingencies
Shareholders' Equity:
Common Stock, $1.00 Par Value Per Share; Authorized 240.0 Shares;
Issued and Outstanding 114.0, 113.6 and 114.6 Shares
114.0
113.6
114.6
Additional Paid-in Capital
11.9
—
—
Accumulated Other Comprehensive Loss
(412.4)
(414.5)
(451.4)
Retained Earnings
1,997.9
2,139.8
2,294.0
Olin Corporation's Shareholders' Equity
1,711.4
1,838.9
1,957.2
Noncontrolling Interests
0.4
31.7
30.6
Total Equity
1,711.8
1,870.6
1,987.8
Total Liabilities and Equity
$ 7,440.6
$ 7,325.8
$ 7,667.9
(a) Unaudited.
Olin Corporation
Consolidated Statements of Cash Flows(a)
Six Months Ended
June 30,
($ in millions)
2026
2025
Operating Activities:
Net Loss
$ (96.3)
$ (1.6)
Depreciation and Amortization
239.3
262.1
Losses of Non-consolidated Affiliates
2.4
1.4
Stock-based Compensation
10.8
10.2
Deferred Income Taxes
(4.0)
(49.5)
Qualified Pension Plan Contributions
(0.6)
(0.6)
Qualified Pension Plan Income
(5.4)
(9.2)
Changes in Assets and Liabilities:
Receivables
(149.0)
(34.1)
Income Taxes Receivable/Payable
2.3
(124.3)
Inventories
(65.9)
(51.8)
Other Current Assets
(12.9)
(10.4)
Accounts Payable and Accrued Liabilities
42.5
108.2
Other Assets
(1.1)
(1.4)
Other Noncurrent Liabilities
(0.5)
27.3
Other Operating Activities
(2.3)
—
Net Operating Activities
(40.7)
126.3
Investing Activities:
Capital Expenditures
(72.7)
(92.4)
Business Acquired in Purchase Transaction, Net of Cash Acquired
—
(55.8)
Investments in Non-consolidated Affiliates
(1.9)
(0.8)
Other Investing Activities
(1.0)
(3.3)
Net Investing Activities
(75.6)
(152.3)
Financing Activities:
Long-term Debt Borrowings, Net
202.3
159.8
Common Stock Repurchased and Retired
—
(30.3)
Stock Options Exercised
3.0
1.9
Dividends Paid
(45.6)
(46.0)
Distributions to Noncontrolling Interests
(31.3)
—
Debt Issuance Costs
(2.1)
(12.0)
Net Financing Activities
126.3
73.4
Effect of Exchange Rate Changes on Cash and Cash Equivalents
(0.2)
0.8
Net Increase in Cash and Cash Equivalents
9.8
48.2
Cash and Cash Equivalents, Beginning of Year
167.6
175.6
Cash and Cash Equivalents, End of Period
$ 177.4
$ 223.8
(a) Unaudited.
Olin Corporation
Non-GAAP Financial Measures - Adjusted EBITDA(a)
Olin's definition of Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income), restructuring charges (income) and certain other non-recurring items. Adjusted EBITDA is a non-GAAP financial measure. Management believes that this measure is meaningful to investors as a supplemental financial measure to assess the financial performance without regard to financing methods, capital structures, taxes or historical cost basis. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP and Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies. Reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures are omitted from this release because Olin is unable to provide such reconciliations without the use of unreasonable efforts. This inability results from the inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations. In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including interest expense (income), income tax provision (benefit), other expense (income) and restructuring charges (income). Because of our inability to calculate such adjustments, forward-looking net income guidance is also omitted from this release. We expect these adjustments to have a potentially significant impact on our future GAAP financial results.
Three Months Ended
June 30,
Six Months Ended
June 30,
($ in millions)
2026
2025
2026
2025
Reconciliation of Net Loss to Adjusted EBITDA:
Net Loss
$ (13.3)
$ (2.8)
$ (96.3)
$ (1.6)
Add Back:
Interest Expense, Net
44.3
45.6
86.4
92.9
Income Tax Provision (Benefit)
17.1
(4.0)
(18.2)
(3.1)
Depreciation and Amortization
122.1
129.9
239.3
262.1
EBITDA
170.2
168.7
211.2
350.3
Add Back:
Restructuring Charges
10.5
7.4
19.6
11.4
Legacy Litigation Matters
—
—
36.1
—
Acquisition-related Costs(b)
10.6
—
10.6
—
Adjusted EBITDA
$ 191.3
$ 176.1
$ 277.5
$ 361.7
(a)
Unaudited.
(b)
Acquisition-related costs for the three and six months ended June 30, 2026 included advisory, legal, accounting, and other professional fees associated with our proposed merger with Huntsman Corporation.
Olin Corporation
Non-GAAP Financial Measures - Net Debt to Adjusted EBITDA(a)
Olin's definition of Net Debt to Adjusted EBITDA is Net Debt divided by Adjusted EBITDA. Net Debt at the end of any reporting period is defined as the sum of our current installments of long-term debt and long-term debt, less cash and cash equivalents. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income), restructuring charges (income) and certain other non-recurring items. Net Debt to Adjusted EBITDA is a non-GAAP financial measure. Management believes that this measure is meaningful to investors as a measure of our ability to manage our indebtedness. The use of non-GAAP financial measures is not intended to replace any measures of indebtedness or liquidity determined in accordance with GAAP and Net Debt or Net Debt to Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies.
June 30,
December 31,
June 30,
($ in millions)
2026
2025
2025
Current Installments of Long-term Debt
$ —
$ 109.7
$ 19.2
Long-term Debt
3,029.1
2,717.6
2,977.5
Total Debt
3,029.1
2,827.3
2,996.7
Less: Cash and Cash Equivalents
(177.4)
(167.6)
(223.8)
Net Debt
$ 2,851.7
$ 2,659.7
$ 2,772.9
Trailing Twelve Months Adjusted EBITDA(b)
$ 567.6
$ 651.8
$ 715.4
Net Debt to Adjusted EBITDA
5.0
4.1
3.9
(a)
Unaudited.
(b)
Trailing Twelve Months Adjusted EBITDA as of June 30, 2026 is calculated as the six months ended June 30, 2026 plus the year ended December 31, 2025 less the six months ended June 30, 2025. Trailing Twelve Months Adjusted EBITDA as of June 30, 2025 is calculated as the six months ended June 30, 2025 plus the year ended December 31, 2024 less the six months ended June 30, 2024.
Dimensional Fund Advisors LP raised its stake in Olin Corporation (NYSE:OLN – Free Report) by 22.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,627,997 shares of the specialty chemicals company’s stock after buying an additional 1,031,498 shares during the quarter. Dimensional Fund Advisors LP owned about 4.94% of Olin worth $167,311,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Royal Bank of Canada lifted its stake in Olin by 20.2% during the first quarter. Royal Bank of Canada now owns 85,198 shares of the specialty chemicals company’s stock worth $2,066,000 after purchasing an additional 14,344 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Olin in the first quarter valued at $32,000. Jones Financial Companies Lllp grew its stake in shares of Olin by 467.9% in the first quarter. Jones Financial Companies Lllp now owns 13,805 shares of the specialty chemicals company’s stock valued at $335,000 after buying an additional 11,374 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Olin by 57.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 588,602 shares of the specialty chemicals company’s stock valued at $14,268,000 after buying an additional 215,235 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Olin by 6.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 317,472 shares of the specialty chemicals company’s stock valued at $7,696,000 after buying an additional 20,047 shares during the period. 88.67% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In OLN has been the topic of several research reports. BMO Capital Markets reduced their price target on shares of Olin from $30.00 to $25.00 and set a “market perform” rating on the stock in a research report on Monday, July 6th. The Goldman Sachs Group dropped their price objective on shares of Olin from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Thursday, July 16th. JPMorgan Chase & Co. cut their target price on shares of Olin from $26.00 to $25.00 and set a “neutral” rating on the stock in a research note on Thursday, June 18th. Zacks Research upgraded shares of Olin from a “strong sell” rating to a “hold” rating in a report on Monday, April 13th. Finally, Citigroup cut shares of Olin from a “neutral” rating to an “underperform” rating in a research report on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, nine have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, Olin has a consensus rating of “Hold” and a consensus target price of $26.46.
View Our Latest Research Report on OLN
Olin Price Performance Shares of OLN opened at $23.21 on Friday. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of -20.73 and a beta of 1.21. The firm’s fifty day simple moving average is $23.23 and its 200-day simple moving average is $24.79. Olin Corporation has a twelve month low of $18.08 and a twelve month high of $30.46. The company has a current ratio of 1.36, a quick ratio of 0.82 and a debt-to-equity ratio of 1.73.
Olin Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Thursday, May 14th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, May 14th. Olin’s dividend payout ratio is -71.43%.
Olin Profile (Free Report)
Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
Further Reading Five stocks we like better than Olin Telecom Earnings Reveal a Sector That Finally Looks Healthier Defense Earnings Show Readiness Now and Modernization Ahead Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off MarketBeat Week in Review – 07/20- 07/24 Want to see what other hedge funds are holding OLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Olin Corporation (NYSE:OLN – Free Report).
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEDimensional Fund Advisors LP Buys 61,404 Shares of Broadridge Financial Solutions, Inc. $BR
NEXT HEADLINE »Voya Financial, Inc. $VOYA Shares Purchased by Dimensional Fund Advisors LP
Wall Street expects a year-over-year increase in earnings on lower revenues when Olin (OLN - Free Report) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 30. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis chlor-alkali and ammunition producer' is expected to post quarterly earnings of $0.07 per share in its upcoming report, which represents a year-over-year change of +40%.
Revenues are expected to be $1.72 billion, down 2.2% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 7.33% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Olin?For Olin, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +42.18%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Olin will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Olin would post a loss of$0.67 per share when it actually produced a loss of -$0.65, delivering a surprise of +2.99%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Olin appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerMethanex (MEOH - Free Report) , another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $4 for the quarter ended June 2026. This estimate points to a year-over-year change of +312.4%. Revenues for the quarter are expected to be $1.41 billion, up 77.4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Methanex has been revised 13.9% up to the current level. Nevertheless, the company now has an Earnings ESP of +0.06%, reflecting a higher Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #2 (Buy), suggests that Methanex will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
On July 22, 2026, Olin Corp (OLN) shares rose 4.7% today, reaching a current price of $24.24. The stock has shown strong momentum recently, with a 10.9% increas
, /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, July 31, 2026, at 9:00 a.m. Eastern time, Olin's senior management will review the company's second quarter 2026 financial results. Our prepared remarks will be followed by a question-and-answer period.
A press release, including financial statements and segment information, will be distributed after the market closes on Thursday, July 30, 2026, together with the associated slides.
CONFERENCE CALL & WEBCAST DETAILS
U.S. callers may access the conference toll-free by dialing (877) 883-0383, while Canadian callers may access by dialing (877) 885-0477 and international callers may access by dialing (412) 902-6506. All callers should use the pass code of 4429090. The call will also be webcast live. Participants may pre-register using the following link: https://app.webinar.net/0ybKMrgk8Pz or access the webcast on July 31 via the company's website at www.olin.com using the second quarter conference call icon. Participants should log on to the website 15 minutes prior to the start of the call.
Following the call, the webcast will remain available for replay on the company's website for one year. A telephonic replay of this conference call will be available beginning at 12:00 p.m. Eastern time for 7 days. U.S. and Canadian callers may access the telephonic replay by dialing (855) 669-9658 and international callers may access by dialing (412) 317-0088. All replay listeners should use the pass code of 6710435.
COMPANY DESCRIPTION
Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges and clay targets.
Visit www.olin.com for more information on Olin Corporation.
, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Olin Corporation (NYSE: OLN) related to its merger with Huntsman Corporation. Upon closing of the proposed transaction, Olin shareholders will own approximately 54.5% of the combined company. Is it a fair deal?
Click here for more info https://monteverdelaw.com/case/olin-corporation/https://monteverdelaw.com/case/psb-holdings-inc/https://monteverdelaw.com/case/xoma-royalty-corporation/https://monteverdelaw.com/case/globalstar-inc-2/https://monteverdelaw.com/case/calisa-acquisition-corp/https://monteverdelaw.com/?post_type=case&p=12170&preview=true. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court? When was the last time you recovered money for shareholders? What cases did you recover money in and how much? About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
Olin and Huntsman have agreed to combine in all-stock deal that creates a North American chemicals company that generated combined revenue of about $12.5 billion last year.
On June 12, 2026, Olin Corp OLN shares rose 3.8% to a current price of $25.13. This price action is situated within a 52-week range of $18.08 to $30.46, showcasing a volatile trading environment over the past year.
GF Value™ verdict: Currently priced at $25.13, OLN is estimated to be 45.1% undervalued compared to its GF Value™ of $45.81.GF Score™: With a score of 65/100, OLN is categorized as above average in terms of overall stock performance potential.Most notable signal: The stock's momentum rank stands at 9/10, indicating strong recent price performance. Is OLN Overvalued or Undervalued? Olin Corp's current share price of $25.13 presents a significant discount when compared to its GF Value™ of $45.81, suggesting that the stock is undervalued by approximately 45.1%. This margin of safety may attract value-focused investors looking for potential opportunities in the market. However, the GF Valuation label indicates that OLN could be a possible value trap, which warrants caution. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
While the significant gap between the stock price and the GF Value™ suggests potential upside, the company's financial strength rating of 3/10 indicates that there are inherent risks associated with investing in Olin Corp. Therefore, while the undervaluation may present an opportunity, investors should be diligent and consider the underlying financial health of the company before making any investment decisions.
How Does OLN's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 199.4x 10.0x The current P/E ratio of Olin Corp at 199.4x is substantially higher than its 5-year median P/E of 10.0x, indicating that the stock is trading well above its historical valuation levels. This P/E analysis supports the GF Value™ verdict of undervaluation; however, it also raises questions about the sustainability of the current price, given the steep valuation compared to historical norms.
What Does OLN's GF Score™ Tell Us? Metric Rating GF Score™ 65 Financial Strength 3/10 Profitability 5/10 Growth 4/10 Valuation 4/10 Momentum 9/10 The GF Score™ of 65/100 indicates that Olin Corp has a sound potential for long-term returns, although it manifests weaknesses in financial strength (3/10), growth (4/10), and valuation (4/10). The strongest aspect of OLN's score is its momentum rank (9/10), suggesting that the stock has been performing well in recent market conditions. Conversely, the low financial strength score points to potential risks that investors should be aware of.
What Are Insiders Doing with OLN Stock? In the past three months, there have been no insider transactions reported for Olin Corp. This lack of activity may suggest that insiders are not currently making significant moves regarding their shares, which can sometimes indicate uncertainty about the company's prospects or a wait-and-see approach regarding future performance.
What This Means for Investors Based on the GF Value™ assessment, Olin Corp is currently undervalued. However, potential investors should proceed with caution due to the company's low financial strength and high current P/E ratio, which may reflect risks that could affect future performance.
For the complete analysis, visit the Olin Corp OLN stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is OLN's GF Score™?
OLN's GF Score™ is 65/100, indicating that the stock is above average in potential for long-term returns based on several key performance metrics.
Is OLN overvalued or undervalued?
Olin Corp is currently undervalued, with a GF Value™ of $45.81 compared to its current price of $25.13, suggesting a potential upside.
What is OLN's P/E ratio?
The current P/E ratio for Olin Corp is 199.4x, which is significantly higher than its 5-year median P/E of 10.0x, indicating it is trading above historical levels.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
SG Americas Securities LLC raised its position in Olin Corporation (NYSE:OLN – Free Report) by 142.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 455,757 shares of the specialty chemicals company’s stock after acquiring an additional 267,458 shares during the quarter. SG Americas Securities LLC owned 0.40% of Olin worth $9,493,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC lifted its position in shares of Olin by 86.6% during the fourth quarter. GAMMA Investing LLC now owns 5,886 shares of the specialty chemicals company’s stock worth $123,000 after purchasing an additional 2,731 shares in the last quarter. Hudson Bay Capital Management LP acquired a new stake in Olin during the 3rd quarter valued at $4,166,000. Allworth Financial LP increased its stake in Olin by 114.0% during the 3rd quarter. Allworth Financial LP now owns 1,740 shares of the specialty chemicals company’s stock worth $43,000 after buying an additional 927 shares during the period. Strategic Advocates LLC purchased a new stake in Olin during the 3rd quarter worth $25,000. Finally, CIBC Bancorp USA Inc. acquired a new position in Olin in the 3rd quarter worth $5,673,000. Hedge funds and other institutional investors own 88.67% of the company’s stock.
Analyst Upgrades and Downgrades OLN has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on shares of Olin from $21.00 to $25.00 and gave the company an “equal weight” rating in a research report on Friday, March 13th. BMO Capital Markets dropped their target price on Olin from $25.00 to $24.00 and set a “market perform” rating on the stock in a research report on Tuesday, February 3rd. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $26.00 price target on shares of Olin in a research note on Tuesday, February 10th. Wall Street Zen downgraded Olin from a “hold” rating to a “sell” rating in a report on Saturday, January 10th. Finally, UBS Group set a $21.00 price objective on Olin in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $23.73.
Get Our Latest Analysis on Olin
Olin Trading Down 0.0% NYSE OLN opened at $29.00 on Monday. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of -76.32 and a beta of 1.56. The company has a debt-to-equity ratio of 1.45, a current ratio of 1.21 and a quick ratio of 0.73. Olin Corporation has a 12 month low of $17.66 and a 12 month high of $29.19. The company’s fifty day moving average price is $24.61 and its two-hundred day moving average price is $23.02.
Olin (NYSE:OLN – Get Free Report) last released its earnings results on Thursday, January 29th. The specialty chemicals company reported ($0.58) earnings per share for the quarter, hitting the consensus estimate of ($0.58). Olin had a negative net margin of 0.63% and a negative return on equity of 0.48%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the previous year, the firm earned $0.09 EPS. The company’s revenue was down .4% on a year-over-year basis. As a group, research analysts predict that Olin Corporation will post 1.38 earnings per share for the current fiscal year.
Olin Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Tuesday, March 3rd were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, March 3rd. Olin’s payout ratio is currently -210.53%.
Insider Buying and Selling at Olin In other Olin news, VP R Nichole Sumner sold 4,750 shares of the company’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $22.49, for a total transaction of $106,827.50. Following the sale, the vice president owned 24,771 shares in the company, valued at $557,099.79. This represents a 16.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, VP Angela M. Castle sold 2,379 shares of the stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $24.25, for a total value of $57,690.75. Following the transaction, the vice president directly owned 1,528 shares in the company, valued at approximately $37,054. This represents a 60.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 99,379 shares of company stock worth $2,238,298 over the last quarter. 1.60% of the stock is owned by corporate insiders.
Olin Company Profile (Free Report)
Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
Further Reading Five stocks we like better than Olin Want to see what other hedge funds are holding OLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Olin Corporation (NYSE:OLN – Free Report).
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINESG Americas Securities LLC Purchases 250,261 Shares of Tencent Music Entertainment Group Sponsored ADR $TME
NEXT HEADLINE »SG Americas Securities LLC Has $9.51 Million Stock Holdings in Dover Corporation $DOV
OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab New anatomic data demonstrates OLN324 achieves faster, greater, and more durable reductions in wAMD pigment epithelial detachment (PED) thickness versus faricimab Ollin and Innovent Biologics advancing OLN324 into global Phase 3 studies in DME and wAMD in 2026 , /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported final, 20-week study completion data from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324(Innovent R&D code IBI324) , a higher-potency, smaller-format, higher-molar dose VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). Final results released include favorable durability data for OLN324 compared to faricimab and new anatomic data showing faster, greater, and more durable control of wAMD pigment epithelial detachments (PEDs) with OLN324.
Topline data from the Week 12 primary endpoint readout, previously announced in January 2026 and presented at the Angiogenesis, Exudation, and Degeneration Symposium in February 2026, demonstrated OLN324, compared to faricimab, delivered superior anatomic outcomes in DME, including faster and greater retinal drying and more patients achieving absence of DME; equivalent retinal drying compared to faricimab in wAMD; rapid and sustained gains in vision in both DME and wAMD that were numerically better than faricimab; and had a favorable safety profile with no cases of intraocular inflammation.
Final 20-Week Study Completion Data Highlights
The JADE trial, which enrolled 164 U.S. patients with either DME or wAMD, all patients initially received three monthly doses of OLN324 or faricimab. Thereafter, they were followed for an additional 12 weeks off treatment, during which they could be retreated based on protocol-specified criteria for disease recurrence that were the same for all groups.
At the final study visit at Week 20, 12 weeks after the last mandatory dose, DME patients treated with OLN324 continued to demonstrate greater retinal drying compared to those treated with faricimab, measured as mean change in central subfield thickness on optical coherence tomography, along with sustained vision gains that were numerically greater for OLN324 4 mg.
These improved efficacy outcomes were achieved with fewer retreatments compared to faricimab. 93% of DME patients randomized to OLN324 4 mg completed 12 weeks of follow-up without retreatment, versus 89% of patients randomized to faricimab.
In wAMD, the rapid and comparable improvements in retinal drying (mean change in OCT CST) observed from Day 1 to Week 12 with OLN324 and faricimab were sustained through Week 20. Patients treated with OLN324 experienced numerically greater vision gains than patients treated with faricimab; the BCVA improvements continued to separate between groups from Weeks 12 to 20, with a mean +2.2 letter advantage observed over faricimab for OLN324 4 mg at Week 20.
82% of OLN324 4 mg patients completed 12 weeks of follow-up without retreatment, compared with 81% of faricimab patients.
OLN324 continued to demonstrate a favorable safety profile, with zero cases of intraocular inflammation observed through the entirety of the study, compared with one case in a faricimab-treated patient. There were no cases of retinal vasculitis or occlusive retinal vasculitis with OLN324.
"These new JADE study data further strengthen the differentiated profile of OLN324, highlighting its robust anatomic efficacy and durability across both DME and wAMD. Combined with a favorable safety profile, these results underscore OLN324's potential to become a first-line treatment option for these vision-threatening diseases," said Jason Ehrlich, M.D., Ph.D., Co-founder and Chief Executive Officer of Ollin Biosciences. "We look forward to advancing OLN324 into global Phase 3 studies in both DME and wAMD later this year. Subject to regulatory communications, we expect the Phase 3 studies to recruit patients from North America, South America, Europe and Japan, and we are actively planning, in partnership with Innovent Biologics, to include China and South Korea."
"We are pleased to see that the latest 20-week data for OLN324 (IBI324) further highlight its differentiated profile and clinical potential," said Dr. Lei Qian, M.D., Ph.D., Chief R&D Officer of General Biomedicine at Innovent Biologics. "We look forward to continuing our close collaboration with Ollin and, following discussions with regulatory authorities, to accelerate the global Phase 3 clinical development of this best-in-disease therapy for retinal diseases."
New Anatomic Results on Pigment Epithelial Detachment (PED) Flattening Highlight Potential for Smaller-Format, Higher-Potency OLN324 to Improve Treatment of wAMD
In newly-available, pre-specified data, wAMD patients in the JADE trial randomized to OLN324 4 mg experienced faster and approximately 50% greater reductions in PED thickness at Week 12 compared to patients randomized to faricimab, measured as mean change in neovascular lesion complex thickness on optical coherence tomography (OCT). Through Week 20, in the off-treatment follow-up period, these improvements were more durable for patients randomized to OLN324 4 mg than faricimab.
"As a field, we've been looking for meaningful advancements that further improve anatomic outcomes in wAMD," said David Eichenbaum, M.D., FASRS, Director of Research, Retina Vitreous Associates of Florida. "These data suggest that OLN324's more potent Ang2 inhibition and smaller molecular format may translate into breaking through the efficacy ceiling experienced with current treatments and offering a clinically-relevant benefit in PED improvement – the most difficult to treat component of wAMD."
Retinal fluid (intraretinal and subretinal) and PEDs are two hallmark anatomic features of wAMD. PEDs are present in approximately 80% of wAMD patients. Persistent PEDs following anti-VEGF treatment are associated with development of subretinal fibrosis, an important cause of late vision loss in wAMD.
Full details of the final JADE study data are expected to be presented at upcoming medical and scientific conferences.
About the OLN324 JADE Study
JADE is a randomized, head-to-head Phase 1b clinical study comparing OLN324, a next-generation VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). More than 160 patients with wAMD or DME were enrolled at sites in the United States. All patients initially received three monthly doses of either OLN324 2 mg, OLN324 4 mg, or faricimab 6 mg. Patients were evaluated at Weeks 1, 4, 8, 12, 16, and 20 and could be retreated at Weeks 12 or 16 based on protocol-specified retreatment criteria that were the same for all groups. The primary objective was to assess safety and tolerability (through Week 12 and Week 20). Prespecified exploratory efficacy objectives included the evaluation of OLN324 vs faricimab on visual acuity and various retinal anatomic parameters.
About OLN324
Building on the clinical success of intravitreal VEGF/Ang2 inhibition, OLN324 is a next-generation VEGF/Ang2 bispecific antibody engineered with substantially higher Ang2 potency relative to faricimab, increased molar dosing relative to both faricimab and aflibercept (including Eylea HD®), and a smaller protein format. VEGF and Ang2 are central drivers of retinal vascular diseases such as diabetic macular edema (DME) and wet (neovascular) age-related macular degeneration (wAMD), with Ang2 playing a key role in vascular instability, leakage, inflammation, and fibrosis. OLN324 was discovered by and is being developed in collaboration with Innovent Biologics (HKEX: 01801; Innovent R&D code: IBI324).
About Diabetic Macular Edema (DME)
Diabetic macular edema, a vision-threatening complication of diabetic eye disease, is a leading cause of vision loss among working-age adults in the developed world. In diabetic macular edema, progressive microvasculature damage, ischemia and microvascular inflammation result in vascular leakage and retinal swelling that compromise vision.
About Wet Age-Related Macular Degeneration (wAMD)
Age-Related Macular Degeneration, a chronic and progressive retinal disease, is the leading cause of vision loss among older adults in the developed world. In wet (or neovascular) AMD, abnormal blood vessels growing beneath the retina leak and bleed, resulting in significant vision impairment.
About Ollin Biosciences
Established in 2023, Ollin BiosciencesTM is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what's possible in ophthalmology. For more information, please visit us at www.ollin.bio and follow us on LinkedIn and X.
About Innovent
Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 18 products in the market. It has 4 assets in Phase 3 or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.
Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.
Disclaimer: Innovent does not recommend any off-label usage.
Vabysmo® is a registered trademark of Genentech, Inc.; Eylea® and Eylea HD® are registered trademarks of Regeneron Pharmaceuticals, Inc.
Forward-looking statement
This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Innovent Biologics ("Innovent"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly.
These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company's competitive environment and political, economic, legal and social conditions.
The Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialise or turn out to be incorrect.
, /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m. Eastern time, Olin's senior management will review the company's first quarter 2026 financial results. Our prepared remarks will be followed by a question-and-answer period.
A press release, including financial statements and segment information, will be distributed after the market closes on Thursday, May 7, 2026, together with the associated slides.
CONFERENCE CALL & WEBCAST DETAILS
U.S. callers may access the conference toll-free by dialing (877) 883-0383, while Canadian callers may access by dialing (877) 885-0477 and international callers may access by dialing (412) 902-6506. All callers should use the pass code of 8428512. The call will also be webcast live. Participants may pre-register using the following link: https://app.webinar.net/K1XV0VJ0oMg or access the webcast on May 8 via the company's website at www.olin.com using the first quarter conference call icon. Participants should log on to the website 15 minutes prior to the start of the call.
Following the call, the webcast will remain available for replay on the company's website for one year. A telephonic replay of this conference call will be available beginning at 12:00 p.m. Eastern time for 7 days. U.S. and Canadian callers may access the telephonic replay by dialing (855) 669-9658 and international callers may access by dialing (412) 317-0088. All replay listeners should use the pass code of 9909423.
COMPANY DESCRIPTION
Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges and clay targets.
Visit www.olin.com for more information on Olin Corporation.
Olin remains a buy as Middle East conflict tightens global petrochemical supply, supporting US-centric producers and improving pricing power. OLN's Q1 likely marks the bottom, with Q2 expected to benefit from lower US natural gas prices and improved margins, especially in Chlor Alkali. Despite weak construction demand, supply disruptions and cost tailwinds should drive at least $150M free cash flow in 2026, with further upside possible.
Olin is expected to implement one of its largest cost-saving goals this year, estimated to be between $100 and $120 million. Given that we are starting to see top line recovery, mainly driven by the epoxy segment, cost savings will bring margin expansion. Momentum, growth, and profitability metrics are improving well and are superior to its peers, but the valuation remains depressed with an upside potential of 68% in case of a re-rating.
First quarter 2026 net loss of ($83.0) million, or ($0.73) per diluted share Quarterly adjusted EBITDA of $86.2 million , /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the first quarter ended March 31, 2026. First quarter 2026 reported net loss was ($83.0) million, or ($0.73) per diluted share, which compares to first quarter 2025 reported net income of $1.4 million, or $0.01 per diluted share. First quarter 2026 adjusted EBITDA of $86.2 million excludes depreciation and amortization expense of $117.2 million, restructuring charges of $9.1 million and legacy litigation charges of $36.1 million. First quarter 2025 adjusted EBITDA was $185.6 million. Sales in the first quarter 2026 were $1,583.0 million, compared to $1,644.2 million in the first quarter 2025.
Ken Lane, President and Chief Executive Officer, said, "During the first quarter, the Olin team delivered sequential improvement in adjusted EBITDA. Our Chlor Alkali Products and Vinyls business benefited from favorable operating cost performance driven by our Beyond250 structural cost actions and lower than expected planned maintenance turnaround expenses. Our Epoxy business returned to positive adjusted EBITDA underpinned by growth in its European business, supported by structurally improved costs at our Stade, Germany facility. Winchester's sequential improvement was driven by actions taken late last year to accelerate channel inventory destocking, as well as improving demand and pricing measures implemented to offset commodity metals and raw materials cost inflation.
"Late in the first quarter, the Iran conflict began to impact trade flows and to increase raw material and feedstock costs. As global supply shortages persist into the second quarter and potentially beyond, our advantaged North American asset base positions us to reliably serve our customers.
"Looking ahead, our Chemicals businesses are expected to deliver sequential earnings improvement driven by seasonally stronger demand and improved pricing, particularly for ethylene dichloride, caustic soda, and epoxy resins. In our Winchester business, improving commercial and military demand are expected to support sequential earnings growth. Overall, second quarter 2026 adjusted EBITDA is forecast to be in the range of $160 million to $200 million," Lane concluded.
SEGMENT REPORTING
Olin defines segment earnings as income (loss) before interest expense, interest income, other operating income (expense), non-operating pension income, other income, and income taxes.
CHLOR ALKALI PRODUCTS AND VINYLS
Chlor Alkali Products and Vinyls sales for the first quarter 2026 were $756.9 million, compared to $924.5 million in the first quarter 2025. The decrease in sales was due to lower volumes, primarily resulting from lower trading volumes associated with Blue Water Alliance, and lower pricing. The Blue Water Alliance joint venture concluded operations at the end of 2025. First quarter 2026 segment loss was ($44.5) million, compared to segment earnings of $78.3 million in the first quarter 2025. The $122.8 million decrease in segment earnings was primarily due to lower pricing and volumes, higher raw material costs, primarily natural gas and electrical power costs, and higher planned maintenance turnaround expenses, partially offset by lower operating costs. Segment results included $36.1 million in legacy litigation costs. Chlor Alkali Products and Vinyls first quarter 2026 results included depreciation and amortization expense of $93.2 million compared to $107.2 million in the first quarter 2025.
EPOXY
Epoxy sales for the first quarter 2026 were $355.6 million, compared to $331.7 million in the first quarter 2025. First quarter 2026 segment loss was ($2.9) million, compared to segment loss of ($28.4) million in the first quarter 2025. The $25.5 million increase in segment results was primarily due to lower operating costs and higher volumes. Product margins were slightly lower year over year. Epoxy first quarter 2026 results included depreciation and amortization expense of $11.9 million compared to $12.8 million in the first quarter 2025.
WINCHESTER
Winchester sales for the first quarter 2026 were $470.5 million, compared to $388.0 million in the first quarter 2025. The increase in sales was primarily due to higher military project revenue and military sales, and higher commercial ammunition sales. First quarter 2026 segment earnings were $15.2 million, compared to $22.8 million in the first quarter 2025. The $7.6 million decrease in segment earnings was primarily due to higher raw material costs, primarily commodity metal costs, and higher operating costs, partially offset by higher commercial ammunition pricing and higher military project revenue. Winchester first quarter 2026 results included depreciation and amortization expense of $8.9 million compared to $9.5 million in the first quarter 2025.
CORPORATE AND OTHER COSTS
Other corporate and unallocated costs in the first quarter of 2026 increased $13.2 million compared to the first quarter 2025 primarily due to higher incentive costs, primarily mark-to-market on stock-based compensation, and an unfavorable impact from foreign currency.
LIQUIDITY AND DIVIDENDS
The cash balance on March 31, 2026, was $192.2 million. Olin ended the first quarter 2026 with net debt of approximately $2.8 billion and a net debt to adjusted EBITDA ratio of 5.1 times. On March 31, 2026, Olin had available liquidity of approximately $1.3 billion, including unrestricted access to the undrawn portion of its revolving credit facility. Working capital increased $56.8 million in the first quarter 2026 due to normal seasonality tempered by a disciplined cash management approach.
On April 29, 2026, Olin's Board of Directors declared a dividend of $0.20 on each share of Olin common stock. The dividend is payable on June 12, 2026, to shareholders of record at the close of business on May 14, 2026. This will be the 398th consecutive quarterly dividend to be paid by the Company.
CONFERENCE CALL INFORMATION
Olin senior management will host a conference call to discuss first quarter 2026 financial results at 9:00 a.m. Eastern Time on Friday, May 8, 2026. Remarks will be followed by a question-and-answer session. Associated slides and the conference call webcast are accessible via Olin's website, www.olin.com, under the first quarter conference call icon. An archived replay of the webcast will also be available in the Investor Relations section of Olin's website beginning at 12:00 p.m. Eastern Time. A final transcript of the call will be posted the next business day.
COMPANY DESCRIPTION
Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges, and clay targets, along with contracted U.S. military project revenue.
Visit www.olin.com for more information on Olin Corporation.
FORWARD-LOOKING STATEMENTS
This communication includes forward-looking statements. These statements relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future results, and current expectations, estimates and projections about the markets and economy in which we and our various segments operate. The statements contained in this communication that are not statements of historical fact may include forward-looking statements that involve a number of risks and uncertainties.
We have used the words "anticipate," "intend," "may," "expect," "believe," "should," "plan," "outlook," "project," "estimate," "forecast," "optimistic," "target," and variations of such words and similar expressions in this communication to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions.
The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the SEC, including without limitation the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, and our Quarterly Reports on Form 10-Q and other reports furnished or filed with the SEC, include, but are not limited to, the following:
Business, Industry and Operational Risks
sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us; declines in average selling prices for our products and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products; unsuccessful execution of our operating model, which prioritizes Electrochemical Unit (ECU) margins over sales volumes; failure to control costs and inflation impacts or failure to achieve targeted cost reductions; availability of and/or higher-than-expected costs of raw material, energy, transportation, and/or logistics; our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation; the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards; exposure to physical risks associated with climate-related events or increased severity and frequency of severe weather events; the failure or an interruption, including cyber-attacks, of our information technology systems; risks associated with our international sales and operations, including economic, political or regulatory changes; weak industry conditions affecting our ability to comply with the financial maintenance covenants in our debt agreements; our indebtedness and debt service obligations; failure to identify, attract, develop, retain and motivate qualified employees throughout the organization and ability to manage executive officer and other key senior management transitions; adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital; our inability to complete future acquisitions or joint venture transactions or successfully integrate them into our business; the effects of any declines in global equity markets on asset values and any declines in interest rates or other significant assumptions used to value the liabilities in, and funding of, our pension plans; our long-range plan assumptions not being realized, causing a non-cash impairment charge of long-lived assets; Legal, Environmental and Regulatory Risks
changes in, or failure to comply with, legislation or government regulations or policies, including changes regarding our ability to manufacture or use certain products and changes within the international markets in which we operate; new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities; unexpected outcomes from legal or regulatory claims and proceedings; costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings; and various risks associated with our Lake City U.S. Army Ammunition Plant contract and performance under other governmental contracts. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements.
2026-06
Olin Corporation
Consolidated Statements of Operations (a)
Three Months Ended
March 31,
($ in millions, except per share amounts)
2026
2025
Sales
$ 1,583.0
$ 1,644.2
Operating Expenses:
Cost of Goods Sold
1,507.2
1,495.5
Selling and Administrative
145.0
101.0
Restructuring Charges
9.1
4.0
Operating (Loss) Income
(78.3)
43.7
Losses of Non-consolidated Affiliates
(1.4)
—
Interest Expense
(43.2)
(48.5)
Interest Income
1.1
1.2
Non-operating Pension Income
3.5
5.7
Income (Loss) before Taxes
(118.3)
2.1
Income Tax (Benefit) Provision
(35.3)
0.9
Net (Loss) Income
(83.0)
1.2
Net Loss Attributable to Noncontrolling Interests
—
(0.2)
Net (Loss) Income Attributable to Olin Corporation
$ (83.0)
$ 1.4
Net (Loss) Income Attributable to Olin Corporation per Common Share:
Basic
$ (0.73)
$ 0.01
Diluted
$ (0.73)
$ 0.01
Dividends per Common Share
$ 0.20
$ 0.20
Average Common Shares Outstanding - Basic
113.8
115.3
Average Common Shares Outstanding - Diluted
113.8
116.6
(a) Unaudited.
Olin Corporation
Segment Information (a)
Three Months Ended
March 31,
($ in millions)
2026
2025
Sales:
Chlor Alkali Products and Vinyls
$ 756.9
$ 924.5
Epoxy
355.6
331.7
Winchester
470.5
388.0
Total Sales
$ 1,583.0
$ 1,644.2
Income (Loss) before Taxes:
Chlor Alkali Products and Vinyls
$ (44.5)
$ 78.3
Epoxy
(2.9)
(28.4)
Winchester
15.2
22.8
Corporate/Other:
Environmental Expense
(5.2)
(5.0)
Other Corporate and Unallocated Costs
(33.2)
(20.0)
Restructuring Charges
(9.1)
(4.0)
Interest Expense
(43.2)
(48.5)
Interest Income
1.1
1.2
Non-operating Pension Income
3.5
5.7
Income (Loss) before Taxes
$ (118.3)
$ 2.1
(a) Unaudited.
Olin Corporation
Consolidated Balance Sheets (a)
March 31,
December 31,
March 31,
($ in millions, except per share data)
2026
2025
2025
Assets:
Cash and Cash Equivalents
$ 192.2
$ 167.6
$ 174.0
Accounts Receivable, Net
915.4
844.5
1,107.3
Income Taxes Receivable
58.7
66.6
15.8
Inventories, Net
827.2
784.5
875.2
Other Current Assets
103.2
107.9
79.0
Total Current Assets
2,096.7
1,971.1
2,251.3
Property, Plant and Equipment (Less Accumulated Depreciation of
$5,565.6, $5,508.7 and $5,291.8)
2,129.3
2,196.9
2,266.5
Operating Lease Assets, Net
301.7
298.6
289.0
Deferred Income Taxes
45.4
47.2
54.5
Other Assets
1,188.2
1,210.0
1,171.6
Intangibles, Net
164.8
174.4
198.6
Goodwill
1,427.7
1,427.6
1,423.5
Total Assets
$ 7,353.8
$ 7,325.8
$ 7,655.0
Liabilities and Shareholders' Equity:
Current Installments of Long-term Debt
$ —
$ 109.7
$ 19.2
Accounts Payable
911.4
806.1
812.0
Income Taxes Payable
13.1
23.9
116.9
Current Operating Lease Liabilities
60.5
59.7
62.5
Accrued Liabilities
558.7
630.1
428.4
Total Current Liabilities
1,543.7
1,629.5
1,439.0
Long-term Debt
2,996.1
2,717.6
3,016.6
Operating Lease Liabilities
254.3
252.5
231.9
Accrued Pension Liability
198.3
200.9
207.6
Deferred Income Taxes
280.7
317.6
417.9
Other Liabilities
346.0
337.1
303.9
Total Liabilities
5,619.1
5,455.2
5,616.9
Commitments and Contingencies
Shareholders' Equity:
Common Stock, $1.00 Par Value Per Share; Authorized 240.0 Shares;
Issued and Outstanding 113.9, 113.6 and 115.1 Shares
113.9
113.6
115.1
Additional Paid-in Capital
4.8
—
—
Accumulated Other Comprehensive Loss
(418.4)
(414.5)
(430.6)
Retained Earnings
2,034.0
2,139.8
2,321.5
Olin Corporation's Shareholders' Equity
1,734.3
1,838.9
2,006.0
Noncontrolling Interests
0.4
31.7
32.1
Total Equity
1,734.7
1,870.6
2,038.1
Total Liabilities and Equity
$ 7,353.8
$ 7,325.8
$ 7,655.0
(a) Unaudited.
Olin Corporation
Consolidated Statements of Cash Flows (a)
Three Months Ended
March 31,
($ in millions)
2026
2025
Operating Activities:
Net (Loss) Income
$ (83.0)
$ 1.2
Depreciation and Amortization
117.2
132.2
Losses of Non-consolidated Affiliates
1.4
—
Stock-based Compensation
4.7
4.0
Deferred Income Taxes
(34.3)
(18.2)
Qualified Pension Plan Contributions
(0.3)
(0.1)
Qualified Pension Plan Income
(3.0)
(5.0)
Changes in Assets and Liabilities:
Receivables
(73.9)
(98.2)
Income Taxes Receivable/Payable
(2.8)
(34.0)
Inventories
(44.3)
(43.9)
Other Current Assets
1.5
4.2
Accounts Payable and Accrued Liabilities
62.7
(32.5)
Other Assets
1.5
4.6
Other Noncurrent Liabilities
6.6
1.1
Other Operating Activities
(2.6)
(1.4)
Net Operating Activities
(48.6)
(86.0)
Investing Activities:
Capital Expenditures
(43.7)
(61.4)
Investments in Non-consolidated Affiliates
(0.3)
—
Other Investing Activities
1.0
(1.0)
Net Investing Activities
(43.0)
(62.4)
Financing Activities:
Long-term Debt Borrowings, Net
170.3
199.9
Common Stock Repurchased and Retired
—
(20.2)
Stock Options Exercised
2.1
1.9
Dividends Paid
(22.8)
(23.0)
Distributions to Noncontrolling Interests
(31.3)
—
Debt Issuance Costs
(2.1)
(12.0)
Net Financing Activities
116.2
146.6
Effect of Exchange Rate Changes on Cash and Cash Equivalents
—
0.2
Net Increase (Decrease) in Cash and Cash Equivalents
24.6
(1.6)
Cash and Cash Equivalents, Beginning of Year
167.6
175.6
Cash and Cash Equivalents, End of Period
$ 192.2
$ 174.0
(a)
Unaudited.
Olin Corporation
Non-GAAP Financial Measures - Adjusted EBITDA (a)
Olin's definition of Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus
an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense
(income), restructuring charges (income) and certain other non-recurring items. Adjusted EBITDA is a non-GAAP financial
measure. Management believes that this measure is meaningful to investors as a supplemental financial measure to assess the
financial performance without regard to financing methods, capital structures, taxes or historical cost basis. The use of non-
GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP and
Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies. Reconciliation of forward-
looking non-GAAP financial measures to the most directly comparable GAAP financial measures are omitted from this release
because Olin is unable to provide such reconciliations without the use of unreasonable efforts. This inability results from the
inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations.
In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including
interest expense (income), income tax provision (benefit), other expense (income) and restructuring charges (income). Because
of our inability to calculate such adjustments, forward-looking net income guidance is also omitted from this release. We expect
these adjustments to have a potentially significant impact on our future GAAP financial results.
Three Months Ended
March 31,
($ in millions)
2026
2025
Reconciliation of Net (Loss) Income to Adjusted EBITDA:
Net (Loss) Income
$ (83.0)
$ 1.2
Add Back:
Interest Expense
43.2
48.5
Interest Income
(1.1)
(1.2)
Income Tax (Benefit) Provision
(35.3)
0.9
Depreciation and Amortization
117.2
132.2
EBITDA
41.0
181.6
Add Back:
Restructuring Charges
9.1
4.0
Legacy Litigation Matters
36.1
—
Adjusted EBITDA
$ 86.2
$ 185.6
(a) Unaudited.
Olin Corporation
Non-GAAP Financial Measures - Net Debt to Adjusted EBITDA (a)
Olin's definition of Net Debt to Adjusted EBITDA is Net Debt divided by Adjusted EBITDA. Net Debt at the end of any
reporting period is defined as the sum of our current installments of long-term debt and long-term debt, less cash and cash
equivalents. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-
back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income),
restructuring charges (income) and certain other non-recurring items. Net Debt to Adjusted EBITDA is a non-GAAP financial
measure. Management believes that this measure is meaningful to investors as a measure of our ability to manage our
indebtedness. The use of non-GAAP financial measures is not intended to replace any measures of indebtedness or liquidity
determined in accordance with GAAP and Net Debt or Net Debt to Adjusted EBITDA presented may not be comparable to
similarly titled measures of other companies.
March 31,
December 31,
March 31,
($ in millions)
2026
2025
2025
Current Installments of Long-term Debt
$ —
$ 109.7
$ 19.2
Long-term Debt
2,996.1
2,717.6
3,016.6
Total Debt
2,996.1
2,827.3
3,035.8
Less: Cash and Cash Equivalents
(192.2)
(167.6)
(174.0)
Net Debt
$ 2,803.9
$ 2,659.7
$ 2,861.8
Trailing Twelve Months Adjusted EBITDA (b)
$ 552.4
$ 651.8
$ 817.4
Net Debt to Adjusted EBITDA
5.1
4.1
3.5
(a)
Unaudited.
(b)
Trailing Twelve Months Adjusted EBITDA as of March 31, 2026 is calculated as the three months ended March 31, 2026 plus
the year ended December 31, 2025 less the three months ended March 31, 2025. Trailing Twelve Months Adjusted EBITDA
as of March 31, 2025 is calculated as the three months ended March 31, 2025 plus the year ended December 31, 2024 less
the three months ended March 31, 2024.
Olin (OLN - Free Report) reported $1.58 billion in revenue for the quarter ended March 2026, representing a year-over-year decline of 3.7%. EPS of -$0.65 for the same period compares to $0.04 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.57 billion, representing a surprise of +1.11%. The company delivered an EPS surprise of +3.1%, with the consensus EPS estimate being -$0.67.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Olin performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Sales- Epoxy: $355.6 million compared to the $348.8 million average estimate based on three analysts. The reported number represents a change of +7.2% year over year.Sales- Chlor Alkali Products and Vinyls: $756.9 million versus the three-analyst average estimate of $798.94 million. The reported number represents a year-over-year change of -18.1%.Sales- Winchester: $470.5 million versus $408.35 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +21.3% change.Income (Loss) before Taxes- Chlor Alkali Products and Vinyls: $-44.5 million compared to the $-31.58 million average estimate based on two analysts.Income (Loss) before Taxes- Winchester: $15.2 million versus the two-analyst average estimate of $4.28 million.Income (Loss) before Taxes- Epoxy: $-2.9 million compared to the $-10.14 million average estimate based on two analysts.View all Key Company Metrics for Olin here>>>
Shares of Olin have returned -0.5% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Olin (OLN - Free Report) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +3.10%. A quarter ago, it was expected that this chlor-alkali and ammunition producer' would post a loss of $0.58 per share when it actually produced a loss of $0.58, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Olin, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $1.58 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.11%. This compares to year-ago revenues of $1.64 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Olin shares have added about 38.3% since the beginning of the year versus the S&P 500's gain of 7.6%.
What's Next for Olin?While Olin has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Olin was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.01 on $1.68 billion in revenues for the coming quarter and -$0.90 on $6.63 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the broader Zacks Basic Materials sector, Avino Silver (ASM - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 13.
This company is expected to post quarterly earnings of $0.07 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Avino Silver's revenues are expected to be $35.1 million, up 86.3% from the year-ago quarter.
Key Takeaways Olin posted a narrower-than-expected Q1 loss as Winchester sales offset weaker Chemicals demand.OLN's Winchester sales jumped on military projects and stronger commercial ammunition demand.Olin expects Q2 EBITDA of $160M-$200M amid stronger demand and pricing improvements. Olin Corporation (OLN - Free Report) reported a first-quarter 2026 adjusted loss of 65 cents per share, narrower than the Zacks Consensus Estimate of a loss of 67 cents, delivering a 3% earnings surprise.
On a reported basis, the company posted a net loss of $83 million, or 73 cents, versus year-ago net income of $1.4 million, or a penny per share.
Sales were $1,583 million, down 3.7% year over year but ahead of the consensus estimate of $1,565.6 million by 1.1%.
Adjusted EBITDA came in at $86.2 million, with results reflecting weaker Chemicals conditions that were partially offset by stronger Winchester sales.
OLN's Segmental ReviewChlor Alkali Products and Vinyls sales were $756.9 million, down from $924.5 million in the year-ago quarter. The reported figure missed the consensus estimate of $799 million. Olin attributed the decline to lower volumes and pricing, with volumes pressured by reduced trading activity tied to the Blue Water Alliance joint venture, which concluded operations at the end of 2025.
Epoxy sales increased to $355.6 million from $331.7 million, supported by higher volumes. The metric beat the consensus estimate of $349 million. Segment loss was lower due to lower operating costs, even as product margins were slightly down year over year.
Winchester sales rose to $470.5 million from $388 million, driven by higher military project revenues and military sales, along with higher commercial ammunition sales. It outpaced the consensus estimate of $408 million.
OLN's FinancialsOlin ended the quarter with cash and cash equivalents of $192.2 million. Net debt was approximately $2.8 billion. Net cash used in operating activities was $48.6 million in the first quarter, compared with $86 million used in the prior-year quarter. Olin paid $22.8 million in dividends and did not repurchase common stock during the quarter.
OLN's OutlookManagement expects sequential improvement in Chemicals in the second quarter, driven by seasonally stronger demand and improved pricing, particularly for ethylene dichloride, caustic soda and epoxy resins. In Winchester, the company sees improving commercial and military demand supporting sequential earnings growth, alongside pricing measures aimed at offsetting raw material inflation.
Olin guided second-quarter 2026 adjusted EBITDA to a range of $160 million to $200 million. The company also noted that the Iran conflict began impacting trade flows late in the first quarter and lifted raw material and feedstock costs, with global supply shortages potentially persisting into the second quarter and beyond.
Olin’s Price PerformanceShares of Olin have gained 26.2% in the past year, compared with 13.1% rise of the industry.
Image Source: Zacks Investment Research
OLN’s Zacks Rank & Key PicksOLN currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Idaho Strategic Resources, Inc. (IDR - Free Report) , NioCorp Developments Ltd. (NB - Free Report) and Hawkins, Inc. (HWKN - Free Report) .
Idaho is expected to report first-quarter 2026 results on May 14. The Zacks Consensus Estimate for earnings is pegged at 43 cents per share, indicating 258.33% year-over-year growth. IDR sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
NioCorp is expected to report third-quarter fiscal 2026 results on May 14. The consensus estimate for NB’s loss per share is pegged at 2 cents, indicating 83.33% year-over-year growth. NB presently flaunts a Zacks Rank #1.
Hawkins is scheduled to report fiscal fourth-quarter 2026 results on May 13. The Zacks Consensus Estimate for HWKN’s first-quarter earnings per share is pegged at 77 cents. HWKN carries a Zacks Rank #2 (Buy) at present.
3 Stocks Ringing in The New Year With Large Buyback AnnouncementsOlin NYSE: OLN executives said the company expects a sharp sequential improvement in second-quarter earnings as higher pricing, seasonal demand and cost reductions begin to flow through results following a challenging but improving first quarter.
Speaking on Olin’s first-quarter 2026 earnings call, President and CEO Ken Lane said the company operated in a “very dynamic” environment while focusing on safety, reliability, liquidity and cost reduction through its Beyond 250 program. Lane said first-quarter results showed early progress, including a return to profitability in the Epoxy business and signs of improving demand for Winchester commercial ammunition.
Get Olin alerts:
The Top 3 Materials Stocks to Buy in NovemberOlin guided for second-quarter adjusted EBITDA of $160 million to $200 million. During the question-and-answer session, Alembic Global Advisors analyst Hassan Ahmed noted that Olin generated about $86 million of EBITDA in the first quarter, asking for a bridge to the midpoint of the second-quarter outlook. Lane said the largest driver of the expected improvement would be the company’s Chlor Alkali Products and Vinyls, or CAPV, segment, supported by higher pricing and volumes as assets return to service.
Chlor-Alkali Outlook Improves on Pricing and Supply Disruptions Lane said the company’s chlor-alkali and vinyls business benefited in the first quarter from lower operating costs, including savings from Beyond 250 and lower-than-expected maintenance turnaround costs. Merchant chlorine demand was seasonally soft but improved from the fourth quarter as year-end destocking ended, while demand into water treatment and crop protection rebounded in mid-March as U.S. temperatures warmed.
Caustic soda remained the stronger side of the electrochemical unit, or ECU, Lane said, with stable global demand and tightening supply. He said several Asian vinyls producers had declared force majeure because of limited feedstock access and rapidly rising costs, constraining chlor-alkali production and reducing availability of co-produced caustic soda. Trade publications estimated that 6% to 9% of annual global vinyls capacity was affected, according to Lane.
The disruption contributed to a sharp increase in global pricing in late March, though Lane said levels had moderated as inventories were depleted. U.S. export EDC prices rose significantly since January, and Olin expects EDC and caustic soda pricing to stabilize at higher levels than earlier in the year as shortages persist and production costs remain elevated.
Lane also said Olin has announced $185 per ton in domestic caustic soda price increases for implementation in the first half of 2026 and is working to implement the balance of those announcements.
Epoxy Returns to Profitability Olin’s Epoxy business returned to profitability in the first quarter, which Lane called an “important milestone.” He said the company expects full-year Epoxy performance to improve meaningfully, helped by regional rationalizations in Europe, cost actions and growth in higher-margin Formulated Solutions markets such as electronics, semiconductors and power generation.
Lane said Olin’s European cost structure is on track to deliver $40 million to $50 million of annual improvement. He also pointed to the recent closure of the company’s plant in Guarujá, Brazil, which he said would further improve the cost structure and strengthen supply integration.
Olin is also seeking higher Epoxy pricing after what Lane described as significant pressure from subsidized Asian supply. The company announced March and April epoxy resin price increases totaling more than $1,200 per ton in North America and EUR 1,300 per metric ton in Europe. Lane said the increases are expected to offset higher feedstock and transportation costs.
Winchester Sees Commercial Ammunition Recovery Lane said Winchester’s first-quarter performance improved significantly after actions in the second half of last year to rebalance channel inventories and improve commercial volume and pricing. Retail shipments are moving back into alignment with out-the-door sales, he said.
As retailer purchases align with demand, Olin expects a mid- to high-single-digit year-over-year uplift in commercial volume. Raw material costs remain a headwind, particularly copper, brass and propellants. Lane said pricing actions should offset the majority of 2025 cost inflation once implemented, though he expects cost pressure to continue through the year.
Winchester is operating under a “make-to-demand” model intended to align with Olin’s value-first commercial strategy, Lane said. He described Winchester as a core part of Olin’s portfolio, citing its brand, retailer relationships, U.S. military business and international customer base.
Liquidity, Cost Savings and Debt Reduction Remain Priorities SVP and CFO Todd Slater said Olin’s top financial priority remains generating cash flow to preserve and enhance liquidity. In February, the company amended its bank credit facilities to provide greater covenant flexibility through late 2027. Slater said Olin has full access to its revolving credit facility and $1.3 billion of available liquidity.
Slater said Olin has no debt maturities before 2029 and expects net debt to rise during the first half of 2026 as it makes payments to resolve legacy litigation matters. The company expects 2026 to be essentially cash-tax free, plus or minus $20 million, after anticipated refunds related to clean hydrogen production tax credits under Section 45V of the Inflation Reduction Act of 2022.
Olin is targeting about $200 million in capital spending for 2026, focused on sustaining capital to support safe and reliable operations. Slater said the company expects to continue its nearly century-long history of uninterrupted quarterly dividend payments and use remaining excess cash flow to reduce debt. Olin expects to end the year with a leverage ratio just above 4 times, while maintaining a long-term goal of averaging below 2 times leverage across the cycle.
Slater also said Olin expects to deliver $100 million to $120 million of incremental savings in 2026 under Beyond 250, after delivering $44 million of structural savings last year. The program is designed to remove more than $250 million of cumulative structural costs by 2028.
Second-Quarter Guidance Includes Freeport Outage Lane said the second-quarter outlook includes the estimated impact of an unplanned vinyls outage at Olin’s Freeport, Texas, plant. The company expects to restart those assets late next week. In response to a question from Vertical Research Partners analyst Kevin McCarthy, Lane said Olin had successfully completed a planned turnaround at the site ahead of schedule and on budget before the unplanned event occurred.
Lane said Olin is not yet near normalized or mid-cycle earnings levels, even with the expected second-quarter improvement. He said the company sees additional upside as demand recovers in housing, infrastructure and general construction, and as chlor-alkali supply-demand dynamics improve amid limited new capacity and likely further rationalization.
“There is still much more leverage here in Olin still to come,” Lane said during the call.
About Olin NYSE: OLNOlin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company's core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin's chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Olin Right Now?Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
On May 29, 2026, Olin Corp OLN shares fell 3.3% to a current price of $25.87, reflecting a broader trend as the stock has decreased 4.8% over the past month. The price has fluctuated between a 52-week high of $30.46 and a low of $18.08.
GF Value™ verdict: Current price of $25.87 is 43.3% undervalued compared to the GF Value™ of $45.61.GF Score™ of 63/100 indicates an above-average stock performance potential.Most notable signal: Momentum rank of 9/10 suggests strong recent performance despite the current price drop. Is OLN Overvalued or Undervalued? The current price of Olin Corp OLN at $25.87 represents a significant discount to the GF Value™, which estimates the fair value at $45.61. This indicates that the stock is trading at a 43.3% margin of safety. However, the GF Valuation label of "Possible Value Trap, Think Twice" introduces caution. While this undervaluation suggests an opportunity, it also implies that the company's fundamentals might not support a recovery to its intrinsic value. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
Investors should be aware that while the stock appears undervalued, the low financial strength score of 3/10 and a Piotroski F-Score of 4 indicate potential underlying issues that could hinder price recovery. The Altman Z-Score of 1.67 also suggests that the company may be at risk of financial distress, raising concerns about the sustainability of any potential gains.
How Does OLN's Valuation Compare to Its History? MetricCurrentHistorical P/E (TTM)Not Available10.0x Forward P/E188.8xN/A As the current P/E ratio is not available, we cannot compare it directly with the 5-year median P/E of 10.0x. However, the forward P/E of 188.8x indicates that the stock is priced significantly above historical valuation levels. This analysis aligns with the GF Value™ verdict, suggesting that while the stock is currently undervalued based on price, it may be overvalued when taking future earnings expectations into account.
What Does OLN's GF Score™ Tell Us? MetricRating GF Score™63/100 Financial Strength3/10 Profitability5/10 Growth3/10 Valuation4/10 Momentum9/10 The GF Score™ of 63/100 suggests that Olin Corp has potential for above-average performance, primarily driven by its momentum rank of 9/10. However, the financial strength score of 3/10 and growth rank of 3/10 indicate significant weaknesses that could affect long-term performance. The profitability and valuation ranks of 5/10 and 4/10, respectively, suggest that while the company has made some strides in profitability, there are still considerable concerns regarding its valuation metrics.
What Are Insiders Doing with OLN Stock? In the last three months, there have been no insider transactions reported for Olin Corp OLN . This lack of insider activity may suggest uncertainty about the company's future prospects, as typically, insider buying can indicate confidence in the company's performance. The absence of buying or selling signals may also indicate that insiders are taking a wait-and-see approach in light of recent stock performance.
What This Means for Investors Based on the GF Value™ analysis, Olin Corp OLN is currently undervalued, trading at $25.87 compared to an estimated fair value of $45.61. However, investors should approach with caution due to the potential value trap indicated by the GF Valuation label and the concerning financial strength metrics.
For the complete analysis, visit the Olin Corp OLN stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is OLN's GF Score™?
OLN has a GF Score™ of 63/100, suggesting that it has above-average potential for performance based on its key aspects.
Is OLN overvalued or undervalued?
OLN is currently undervalued, with a GF Value™ of $45.61 compared to its current price of $25.87, indicating a 43.3% margin of safety.
What is OLN's P/E ratio?
The current P/E ratio for OLN is not available, but the forward P/E is 188.8x, suggesting that the stock is trading at a premium compared to its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
On June 04, 2026, Olin Corp OLN shares fell 3.2% today, currently trading at $24.93. This price movement is particularly notable given the stock's 52-week range of $18.08 to $30.46. The following points summarize the current valuation context:
GF Value™ verdict: Current price of $24.93 vs GF Value™ of $45.73, indicating a 45.5% upside.GF Score™ of 65/100, suggesting the stock is rated as Above Average.Most notable signal: Momentum rank of 9/10, indicating strong price performance relative to peers. Is OLN Overvalued or Undervalued? The current trading price of Olin Corp OLN at $24.93 is significantly lower than its GF Value™ estimate of $45.73, which suggests that the stock is undervalued by approximately 45.5%. This margin of safety could provide an attractive opportunity for investors looking for potential growth. However, it is essential to consider the GF Valuation label, which identifies OLN as a Possible Value Trap, indicating that while the stock appears undervalued, there may be underlying issues that could impede future price appreciation.
GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. The substantial difference between the current price and the GF Value™ raises questions about the sustainability of OLN's financial health and operational effectiveness, particularly given its low financial strength rating of 3/10.
How Does OLN's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 197.9x 10.0x Olin Corp's current P/E ratio of 197.9x is significantly higher than its 5-year median P/E of 10.0x. This indicates that the stock is trading well above its historical valuation levels. The P/E analysis aligns with the GF Value™ verdict, which suggests that the stock is undervalued but warns of potential risks. This discrepancy signals that while there may be short-term opportunities, caution is warranted given the inflated P/E ratio.
What Does OLN's GF Score™ Tell Us? Metric Rating GF Score™ 65 Financial Strength 3/10 Profitability 5/10 Growth 4/10 Valuation 4/10 Momentum 9/10 The GF Score™ of 65/100 indicates that Olin Corp is rated as Above Average in comparison to its peers. The strongest area in OLN's score is its momentum rank of 9/10, highlighting its recent price performance. However, the weakest aspect is its financial strength rating of 3/10, suggesting potential vulnerabilities in its balance sheet and overall financial health. Investors should consider these strengths and weaknesses when evaluating the stock's potential for growth.
What Are Insiders Doing with OLN Stock? Recent insider activity for Olin Corp shows no transactions in the last three months, indicating a lack of significant buying or selling from executives and board members. This absence of insider activity could suggest a cautious approach among insiders regarding the company's future prospects, or it may reflect a wait-and-see strategy in light of current market conditions.
What This Means for Investors Based on the GF Value™ assessment, Olin Corp OLN is currently undervalued at a price of $24.93 compared to its GF Value™ of $45.73. However, potential investors should proceed with caution due to the possible value trap indicated by the GF Valuation label and the low financial strength rating.
For the complete analysis, visit the Olin Corp OLN stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is OLN's GF Score™?
OLN's GF Score™ is 65/100, indicating that the stock is rated as Above Average based on key financial metrics and historical performance.
Is OLN overvalued or undervalued?
OLN is considered undervalued, with a GF Value™ of $45.73 compared to its current price of $24.93, suggesting a potential upside.
What is OLN's P/E ratio?
OLN's current P/E ratio is 197.9x, which is significantly higher than its 5-year median P/E of 10.0x, indicating that the stock is trading well above its historical valuation levels.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].